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Abstract
Molecular Simulations of HIV-1 gp41 Protein-Membrane Interactions
Vamshi K. Gangupomu
Advisors: Franco M. Capaldi, Ph.D., Cameron F. Abrams, Ph.D.
Cellular and viral membrane fusion is a critical process during viral infection. The
HIV-1 surface envelope glycoprotein (gp41) anchored in the cholesterol-rich host cell
derived viral membrane is responsible for mediating membrane fusion between the
viral and target-cell membranes. The objective of this thesis is to understand the role
of cholesterol and gp41, specifically the membrane spanning domain (MSD) and the
two ectodomain heptad repeats (N-terminal heptad repeat and C-terminal heptad
repeat), during membrane fusion using all-atom molecular modeling.
The 27-residue membrane-spanning domain (MSD) of the HIV-1 glycoprotein
gp41 bears conserved sequence elements crucial to the biological function of the virus,
in particular a conserved mid-span arginine Arg694. We found that the MSD assumes
a stable α-helical conformation and metastable kinked conformations that differ de-
pending upon whether Arg694 side-chain snorkels towards the exoplasmic or endo-
plasmic side of the viral membrane. It was observed that when the Arg694 side-chain
snorkels towards the endoplasmic headgroups the MSD assumes a kinked conforma-
tion that was hypothesized from experimental studies. Moreover, we found significant
local thinning of the membrane and penetration of water molecules into the mem-
brane core in the presence of mid-span Arg694. The presence of cholesterol in the
lipid membrane was found to assist in better anchoring of a non-polar structure in
the membrane while increasing the free-energy of membrane destabilization. Mechan-
ically destabilizing a cholesterol-rich lipid membrane also resulted in the formation of
a larger rupture pore compared to a pure POPC lipid bilayer. Model built structures
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of the gp41 ectodomain were then used to simulate folding of the gp41 pre-fusion in-
termediate into a stable six-helix bundle. These models provided important insights
into the mechanism of folding and the specific interactions involved during folding.
Membrane fusion requires that the opposing membranes are brought into prox-
imity and destabilized to facilitate lipid mixing. The membrane lipids and fusion
proteins in both the membranes play important roles in facilitating membrane fusion.
In this work we showed specific roles cholesterol and HIV-1 gp41 play in priming the
viral membrane to promote fusion.
1Chapter 1: Introduction
1.1 Background and Motivation
The acquired immunodeficiency syndrome (AIDS) pandemic caused by the human
immunodeficiency virus type 1 (HIV-1) currently affects an estimated 33.4 million
people worldwide and infects 2.5 million people each year. Twenty seven years after
the first publication reported the pathogen and its role in the etiology of AIDS,
a vaccine to prevent HIV-1 infection is still elusive [2–6]. HIV compromises the
human immune system, specifically targeting the CD4+ T-cells, and quickly reverse-
transcribes to form a latent reservoir of infected T cells resulting in a depletion of
memory T-cells making it a much more formidable adversary compared to viruses such
as influenza. The recent Thailand trails involving a combination of a recombinant
canarypox vector vaccine (ALVAC-HIV [vCP1521]) and a recombinant glycoprotein
120 subunit booster vaccine provided promising results [7]. However, the sequence
and strain diversity of HIV along with its ability to mutate and adapt presses upon
the need to find new vaccine mechanism and targets [3, 5]. Considering the prevalence
of AIDS in the low-income group countries a major challenge is to provide inexpensive
vaccines. Therefore research is now being focused to develop an understating of HIV
and targets to develop safe and efficient vaccines.
One of the most basic yet important targets are the surface envelope glycoproteins
of HIV. Env is a trimeric complex heterodimers including receptor-binding glycopro-
tein 120 (gp120) and membrane-spanning glycoprotein 41 (gp41). The env complex
2is responsible for viral tropism and fusion of the viral and target cell membranes
leading to infection [8, 9]. Some early efforts included using monomeric gp120 to
induce humoral immune responses. However, env gp120 immunogens failed to induce
broadly neutralizing antibodies and production of cytotoxic T cells. Another promis-
ing strategy to hinder viral infection is to prevent the fusion of the viral and target
cell membranes by inhibiting the conformational changes in gp41 that facilitate mem-
brane fusion. The peptide T20, a 36 amino acid long peptide from the C-terminal
heptad repeat of gp41, and the monoclonal antibodies 2F5 and 4E10, that bind to
specific linear binding sites in the membrane proximal external region (MPER) be-
long to this category [10–15]. The ability of HIV-1 to mutate and the rapid folding
of gp41 into a very stable six-helix bundle might however make these ineffective. Un-
derstanding the structure and function of env glycoproteins and their effects on viral
and target cell membranes provide a first step towards developing safe and effective
fusion inhibiting vaccines.
1.2 Lipid Membranes
Lipids are amphiphilic biomolecules that have diverse biological functions as en-
ergy storage components in the form of fats and oils, enzyme cofactors, signaling
molecules, pigments and as biological membranes [16]. In aqueous media, lipids spon-
taneously form into macromolecular structures such as micelles and bilayers. Lipid
bilayers are planar structures that are biologically important since they form the basis
for cell plasma membranes that protect the cell from its environment and organelle
membranes that compartmentalize cellular contents. Plasma membranes function as
selective permeability barriers while also acting as a solvent for membrane proteins
assisting in various functions such as cell signaling, ion transport and cell adhesion.
The intricate interactions between the lipid molecules and the membrane proteins are
3critical for their biological function. Therefore, the cell plasma membranes are com-
plex structures containing a vast array of lipids that reflect their biological function.
Figure 1.1: A schematic cross-section of a lipid membrane with 10% cholesterol. The lipid head
groups are shown in van der Waals representation. Cholesterol is shown in cyan and POPC in tan.
Water is shown as points in red on both the exoplasmic and endoplasmic sides of the membrane
The fluid mosaic model, by Singer and Nicholson in 1972, proposed that lipid
membranes are complexes of proteins diffusing freely in a fluid lipid bilayer [17]. The
amount of protein/lipid ratio and the lipid composition of plasma membranes vary
widely not only between cell types but also between the inner and outer leaflets of the
plasma membranes. However, the two predominant lipids in the plasma membranes
4of eukaryotic cells are phospholipids and cholesterol. Carbohydrates are covalently
attached to either the proteins or lipids and make up about 10% weight in plasma
membranes [18]. Research into specific interactions between cholesterol and phos-
pholipids in plasma membranes resulted in the discovery of phase separation in lipid
bilayers [19]. Cholesterol rich lipid domains that formed a rigid liquid-ordered phase
(Lo) were observed to coexist within a more fluid liquid-disordered phase (Ld). These
cholesterol rich domains or “rafts” gathered immense research interest and were found
to sequester a variety of membrane proteins and play and important role in cell sig-
naling, viral entry, immune response and cell adhesion [20–27].
1.2.1 Phospholipids
Phospholipids are the most abundantly found lipid molecules in biological mem-
branes [16]. The basic structure of most phospholipids consists of a glycerol backbone,
a phosphorylated alcohol polar “head” group and two fatty acid chains as the non-
polar “tail” groups. The carboxyl groups of the two fatty acids chains are esterified
to the C-1 and C-2 hydroxyl groups of glycerol and are called the sn-1 and sn-2
chains respectively(Fig. 1.2). The head group is esterified to the C-3 hydroxyl group
of glycerol backbone. The most common alcohol moieties present in the mammalian
plasma membrane lipid head groups are choline(PC) and etholamine(PE) followed
by serine(PS) and inositol(PI) to a much lesser extent [18]. The fatty acid chains are
typically 14 to 22 carbon atoms long and for the hydrophobic core of lipid bilayers.
These acyl chains can be derived from saturated fatty acids as in palmitic acid (C16),
or unstaturated fatty acids like oleic acid (C18-1). The unsaturated fatty acids chains
are usually found in the sn-2 position. The length of the acyl chains and the degree
of unsaturation has a profound effect on membrane structure and fluidity.
5Figure 1.2: Representation of lipid molecules. 1-palmitoyl-2-oleoyl-phophatidylcholine (POPC)
with monounsaturated sn-2 chain, 1,2-dipalmitoylphosphatidylcholine (DPPC) and cholesterol
1.2.2 Cholesterol
Cholesterol is a major component of eukaryotic cell plasma membranes and is
thought to be important for cell growth [18]. The structure of cholesterol consists
of a small polar 3β-hydroxyl group followed by a very hydrophobic planar fused ring
structure and a hydrocarbon side chain(Fig. 1.2). The 3β-hydroxyl group allows
cholesterol to position itself parallel to the acyl chains of the lipid molecules. The
planar ring structure of cholesterol then increases the motional order of the lipid tails
above the phase transition temperature of the lipid molecules resulting in a densely
packed lipid molecules and a rigid membrane structure as observed in a liquid-ordered
(Lo) state [28]. The rigid fused ring structure enables cholesterol to interact more
favorably with lipids containing straighter saturated acyl chains than the kinked un-
saturated tail groups. Below the lipid phase transition temperature, i.e. with the
lipid membrane in the gel phase, cholesterol increases the free space between lipid
molecules thereby increasing hydrocarbon chain disorder and making the membrane
6more fluid [29–32]. The ability of cholesterol to manipulate membrane fluidity and
properties likely make it important for membrane protein function and explains the
highly energy intensive synthesis and specificity of the sterol in eukaryotic cells [18].
Moreover, cholesterol-rich domains in plasma membranes are known to localize certain
proteins. These proteins have specific structural domains that interact with choles-
terol. Examples of these structural domains are the cholesterol recognition amino
acid consensus (CRAC) domain and the sterol-sensing domain (SSD) [33].
1.3 Membrane fusion
Membrane fusion is important for various processes in nature including endocyto-
sis, nuerotransmission, organelle formation and viral infection and typically consists
of a two-step process [34, 35]. In step one, the opposing membranes are brought into
close proximity in the aqueous environment against the counteracting electrostatic
forces. In the second step the membranes are destabilized to facilitate lipid mixing
and fusion [35]. A variety of proteins and lipids are involved to control and coordinate
the fusion process. The most studied of these fusion proteins are the viral envelope
proteins and the SNARE proteins that mediate intracellular fusion events [34, 35].
1.3.1 Fusion proteins
Viral fusion proteins can be divided into two major classes based on their struc-
tural features [36]. Class I proteins consist of paramyxo-, filo-, retro- and orthomyx-
oviruses and include HIV-1 (Env) and influenza (HA) fusion proteins [34]. Class I
proteins typically have a fusion-inactive precursor that is proteolytically cleaved into
a fusion active receptor-binding protein and a membrane anchored protein with an
amino-terminal fusion peptide. These proteins assume a characteristic stable triple
stranded post-fusion coiled-coil structure. Class II viral proteins are not proteolyt-
7ically cleaved and have an internal fusion peptide. The flavi- and alphaviruses are
thought to have class II fusion peptides. The structure and function of Class I fusion
peptides, especially HA, are the most studied and excellent review articles on both
Class I and II proteins are available [36]. A detailed description of the HIV-1 Env is
provided in section 1.4 .
SNARE protein complexes mediate the synaptic vesicle fusion with the plasma
membrane and have been proposed to be essential for hundreds of intracellular mem-
brane fusion events [37–39]. The SNARE complex involves the formation of a stable
four-helix bundle where the vesicle associated synaptobrevin contributes one helix
and the target-membrane associated SNAP-25 and syntaxin contribute three helices.
A common structural feature between the SNARE complexes and class I viral pro-
teins are the conserved heptad repeats that are responsible for the formation of stable
helical bundles while pulling the opposing membrane to close proximity [38].
1.3.2 Fusion mechanism
It was postulated that the fusion process involves at least two steps [18, 34, 35]. In
the first step the proximal layers of the opposing membranes merge to form a “stalk”.
In the second step the distal monolayers merge to form a hemi-fusion intermediate
the eventually grows into a fusion pore. The merging of the bilayer requires that
the membranes are destabilized to facilitate interaction between the hydrophobic
tail groups of the lipids. However, there are still large gaps in understanding the
mechanism of membrane fusion and the specific way the fusion proteins destabilize
the membranes to catalyze the fusion process [18].
81.4 The human immunodeficiency virus type 1 (HIV-1)
HIV-1 is a retrovirus and has an RNA genome that is reverse transcribed and inte-
grated into the host DNA during infection. The life cycle of HIV-1 starts as a mature
virion approaches a target cell for infection [40]. Viral entry is mediated by the surface
envelope glycoproteins (Env). The envelope glycoprotein gp160 is post-transitionally
cleaved into two non-covalently linked subunits, gp120 and gp41. Viral tropism is di-
rected by gp120 that binds to the cell receptor CD4 and co-receptors CCR5/CXCR4.
Gp120 receptor binding induces rapid but poorly understood conformational changes
in the Env gp41 transmembrane protein which initiates fusion [8, 9, 41, 42]. These
conformational changes result in the exposure followed by insertion of a hydrophobic
fusion peptide (FP) of gp41 into the target cell membrane. Following FP insertion
another cascade of conformational changes results into the gp41 folding into a vary
stable six-helix bundle thereby bringing the viral and target-cell membranes within
close proximity inducing membrane fusion and the delivery of the viral capsid into
the target cell. The viral capsid consists of the enzymes reverse transcriptase and
integrase, the viral RNA and the viral protein Vpr that assists in transporting the
capsid contents into the host cell nucleus.
In the nucleus, the RNA is reverse transcribed by reverse transcriptase and is
incorporated in the host-cell chromosome. The synthesized RNA is transported back
into the cytoplasm where the viral core is assembled. Gp160 is cleaved into gp120
and gp41 and will be in a complex with CD4 in the endoplasmic reticulum. The viral
protein Vpu degrades CD4 and enables Env transport to the plasma membrane in the
form of trimeric spikes of gp120/gp41 dimers. The env spikes are assembled into the
plasma membrane and the virion buds using the host-cell derived membrane. During
this process HIV-1 is believed to assemble the env spikes and bud from cholesterol
rich domains present in the host-cell membrane. Therefore, the HIV-1 viral lipid coat
9is rich is saturated lipids and cholesterol. After the virion is released from the host-
cell membrane it matures into an approximately 100 nm diameter virus and ready to
repeat the life cycle.
1.4.1 Glycoprotein-41
Gp41 is often described structurally in terms of five major regions: 1. a glycine
rich fusion peptide (FP) that is exposed upon the conformational changes following
gp120 binding to CD4 and CCR5/CXCR4 and inserts into the target cell membrane,
2. a core consisting of the N- and C-terminal heptad repeats (NHR and CHR),
that following FP insertion form a six-helix bundle bringing the target membrane
and viral membrane together, 3. a membrane proximal external region (MPER)
following the CHR, that contains a CRAC segment that is thought to be responsible
for sequestering the peptide in cholesterol-rich domains, 4. a membrane spanning
domain (MSD), that is thought to anchor gp41 to the viral membrane and 5. a long
cytoplasmic tail that extends into the endoplasmic side of the virion [43–45]. Although
their triggering mechanisms can be different, the ectodomain core complexes of various
viral membrane fusion proteins have remarkably similar structures [8, 46]. The role of
the fusion peptide of viral fusion proteins, including influenza(HA) and HIV-1(Env),
in initiating viral infection by inserting itself in to the target cell membrane and the
formation of the six-helix bundle to bring the target cell membrane and the viral
membrane closer to each other has been well studied [47, 48]. Since, proximity of
the membranes is not sufficient for membrane fusion there should be a mechanism
for the virus to destabilize its own membrane. Therefore recent experimental studies
were focused on understanding the conformation of the MSD and its role in viral
membrane destabilization [49–51]. Although molecular simulations were proved to be
an invaluable tool in studying and visualizing protein structure and dynamics, the
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absence of crystallographic or nuclear magnetic resonance (NMR) structure of the
HIV-1 MSD hindered molecular simulation studies of HIV-1 MSD [52].
The complete mechanism of HIV-1 infection, the membrane fusion process and
the function of various viral proteins during infection are provided in some excellent
reviews [8, 40, 53, 54]. The main goal of this work is to explore a structure-function
relationship of gp41, specifically the membrane spanning domain (MSD) that anchors
the env to the viral membrane and its effect on the viral membrane using molecular
simulations.
1.5 Objectives and specific aims
To achieve the objective of understanding gp41 MSD effects on viral membrane, we
started by studying the effects of cholesterol on the forces and free-energies required
to rupture lipid bilayer.
1.5.1 Specific Aim 1: Compute the forces and free-energies of membrane
rupture
An important component of molecular simulations is to validate the results gener-
ated by the simulations by comparing reliable observable properties with experimental
data. In Chapter 3 we validate the results by comparing the surface area per lipid
obtained from our simulations of pure POPC and POPC bilayers with 10%, 30%
and 50% cholesterol. We also study the effect of cholesterol content on membrane
properties, specifically the membrane thickness and the lipid order parameters. We
then simulated mechanical rupture of pure POPC and POPC bilayers containing 30%
cholesterol using a pristine carbon nanotube. The dimension of the nanotubes were
chosen to replicate a viral fusion peptide and were approximately 20 A˚ in length and
12 A˚ in diameter. We used these simulations to compute the forces and free-energies
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required to penetrate a lipid bilayer with a predominantly non-polar structure and
the effects of cholesterol on these force and free-energies.
1.5.2 Specific Aim 2: Structure and orientation of HIV-1 gp41 MSD and
effects on lipid membrane structure
The HIV-1 gp41 MSD likely plays an important role in the destabilization of the
viral membrane during infection. In Chapters 4 and 5 we study the structure of gp41
MSD in water and a cholesterol-containing lipid bilayer respectively. The MSD has a
mid-span Arg694 that is important for its function. Specifically, we study the impor-
tance of the mid-span Arg694 by testing (i) the effect of Arg694 snorkeling direction
on the MSD structure in a membrane, and (ii) the Arg694→Leu point mutation to
replace Arg694 which abrogates infectivity.
1.5.3 Specific Aim 3: Folding of gp41 ectodomain from a pre-fusion in-
termediate (PFI) to a six-helix bundle (6HB)
Folding of the gp41 ectodomain from a PFI conformation to the stable 6HB re-
sults in bringing the viral and target-cell membrane into close proximity leading to
membrane fusion. These series of conformational changes likely assist in viral mem-
brane destabilization of the MSD. We simulate the folding of the ectodomain into
a 6HB from a pre-fusion intermediate to provide a first step towards understanding
the interactions involved during the process. In Chapter 6 we provide the simulation
details of the folding of a PFI into a 6HB using TMD.
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Chapter 2: Simulation Methods
2.1 Introduction
Molecular simulations are the tools for study and analysis of molecular structure
and function. Molecular simulations are now being used to study various biological
systems, most importantly proteins, lipids and nucleic acids [52, 55, 56]. These simu-
lations can be especially powerful to explore, observe and understand experimentally
inaccessible phenomena in a cheap, safe and efficient way [57].
Molecular simulations need models with atomic level detail, the interactions of
which are then computed to study their macroscopic properties. These models are
initial configurations of atoms in space that are typically obtained from experimental
data such as nuclear magnetic resonance (NMR) or X-ray crystallography. In the
absence of this data, a thorough knowledge of the system can used to model build
structures [55]. The interactions between these atoms are then described using an
empirical potential energy function. Although quantum mechanics can be used to
describe these interactions, for many atomic systems quantum mechanical calculations
are computationally expensive. Therefore classical mechanics, in which the energy of
the system is calculated only based on nuclear positions ignoring electron motion, is
best suitable for large biological macromolecules. Force fields have been developed
with the help of experiments and quantum mechanical calculations [58, 59]. Using
these initial structures and force fields, molecular simulations generate information
at the atomic level in the form of a series of snapshots of the system.
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2.1.1 Statistical mechanics and ensembles
Experimentally observable macroscopic properties are calculated from the micro-
scopic information using statistical mechanics. Each particular snapshot with unique
internal coordinates and momenta of particles can be described as a microscopic state.
In a system with N particles, where N is large, there can be a large number of mi-
croscopic states that collectively conform to a macroscopic state characterized by a
handful of thermodynamic variables. A collection of microscopic states that have an
identical macroscopic state is called an ensemble. Different kinds of statistical ensem-
bles exist that are characterized by fixed values of thermodynamic values such as the
total number of particles N, volume V, temperature T, total energy E, or chemical
potential µ. The canonical ensemble is characterized by constant NVT, the micro-
canonical ensemble by constant NVE, the grand canonical ensemble by µVT and the
isobaric-isothermal ensemble by NPT [58–60].
The value of an observable property of a system depends on the positions and
momenta of the N particles of the system. Therefore, the instantaneous values of
a property A can be described as A(p(t), r(t)) where r and p are the positions
and momenta of the N particles respectively at time t. The instantaneous value of
A fluctuates in time because of the chaotic motion of the particles. To obtain an
experimentally observable value we must average A over time. As the time over
which the measurement is made increases to infinity the time average value reaches
the “true” average of the property as given by:
A¯ = lim
τ→∞
1
τ
∫ τ
0
A(r(t),p(t)) dt, (2.1)
Since, most macroscopic systems are large (in the order of 1023 particles), it is im-
practical to simulate the dynamic behavior of the particles as expected by the time
averaging. In such cases, the time average can be replaced by an ensemble average
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given by:
〈A〉ensemble =
∫ ∫
dpdrA(p, r)P (p, r), (2.2)
where the 〈〉 brackets indicate and ensemble average and P is the probability density of
the ensemble, defined as the probability of observing a microstate (p,r). The ensemble
average of a property A can therefore be determined by averaging over all possible
configuration of the system and its use is facilitated by the ergodic hypothesis, which
states that the ensemble average is equal to the time average.
In the canonical ensemble the probability density is given by
P (p, r) =
1
Z
exp (−H(p, r)/kBT ), (2.3)
where H is the Hamiltonian of the system, defined as H = K + U, where K is the
kinetic energy of the system and U is the potential energy of the system. kB is the
Boltzmann constant, T is the temperature of the system and Z is called the partition
function given by
Z =
∫ ∫
dpdr exp (−H(p, r)/kBT ), (2.4)
If we know the partition function of the system, we can derive all other thermody-
namics properties of the system from it. For example:
U = kBT
2
(
∂ lnZ
∂T
)
V,N
, (2.5)
S = kB lnZ +
U
T
, (2.6)
F = −kBT lnZ. (2.7)
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There are two major approaches in molecular simulations to derive these properties:
1) Molecular dynamics (MD), which is a deterministic approach and studies the dy-
namics by simulating the time evolution of the system and 2) Monte Carlo (MC) which
is a stochastic approach. Molecular dynamics can therefore be used to extract both
the kinetic and thermodynamics properties of the system while MC can be used to
calculate thermodynamic properties of the system. Some excellent texts and reviews
can be found on both these methods and the statistical mechanics [55, 56, 58–60].
However, in this work only MD was used and therefore a brief introduction of MD
is provided in Section 2.2. This is followed by the force fields used in this work, the
limitations of MD and other simulation techniques used in this thesis.
2.2 Molecular Dynamics
Molecular dynamics simulates the time dependent dynamics of a system of inter-
acting particles and is a major simulation technique used to study biological macro-
molecules. MD can be used to extract kinetic and thermodynamic information, to
refine macromolecular structures based on NMR and X-ray crystallographic data, and
to study the free-energy changes and requirements in biological systems. To access
these properties using MD simulation requires knowledge of the empirical interatomic
potential that describes the interactions between various atoms. The forces acting
on these atoms are gradients of this potential, and can be used in the integration
of Newtonian equations of motion to predict the evolution of particle positions and
momenta.
2.2.1 Langevin Thermostat
Since the total energy E is not conserved in an NVT ensemble a thermostat
is needed to constantly add to remove energy from the system. In the Langevin
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thermostat each particle is coupled with a heat bath and the fundamental equation
of motion F = ma is modified into the Langevin equation
mir¨i = −
(
∂U
∂ri
)
− γmir˙i + ηi(t), (2.8)
where m is the mass, beta, kB is the Boltzmann’s constant and T is the temperature.
U is the interatomic potential, γ is the friction constant, η is the random force or the
Gaussian white noise, which obeys a fluctuation-dissipation theorem
〈ηi(t)ηj(t
′)〉 = δijδ(t− t
′)6kBTγmi (2.9)
2.2.2 Numerical Integration
During an MD run the Langevin equation is numerically integrated to propagated
the system in time. One the most widely used and efficient integrating schemes is
the velocity-Verlet algorithm. The velocity-Verlet algorithm is accurate, fast and
time reversible [58, 61]. This algorithm updates the coordinates and velocities of the
particles at the next time step (r(n+1)) from the current one (rn) using
vn+1/2 = vn +M
−1Fn∆t/2, (2.10)
rn+1 = rn + vn+1/2∆t, (2.11)
Compute, Fn+1 = F (rn+1),
vn+1 = vn+1/2 +M
−1Fn+1∆t/2. (2.12)
where δt is the time step and M is the mass matrix.
To start an MD simulation, apart from assigning the atomic coordinates of the sys-
tem, the initial velocities should also assigned. The velocities are randomly assigned
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for each particles from a Maxwell-Boltzmann distribution for the desired temperature:
P (v) =
(
mi
2πkBT
)1/2
exp
[
−
1
2
miv
2
kBT
]
. (2.13)
The Maxwell-Boltzmann equation gives the probability that atom i of mass mi has a
velocity v at a temperature T. The instantaneous value of the temperature is related
to the kinetic energy via the particles’ momenta pi by:
H =
N∑
i=1
|pi|
2
2mi
=
kBT
2
(3N − 6). (2.14)
where H is the Hamiltonian of the system, and 3N-6 is the total number of degrees of
freedom for a 3 dimensional system. The temperature control for MD simulations in
this work was achieved via Langevin thermostat (Eq 2.8). Other techniques for tem-
perature control include Andersen thermostat [62], and Berendsen thermostat [63].
The pressure control in all MD simulations presented in this work was achieved by
the Nose´-Hoover barostat [64–68].
2.2.3 Force Field
Molecular dynamics simulations start with the knowledge of empirical potential
functions or force fields that describe the interactions between atoms. These potential
functions contain information about the system components such as the bond lengths,
bond angles, torsion angles and the non-bonded interactions that treat the Van der
Waals and electrostatic interactions. The empirical potential used in this thesis is the
Chemistry at HARvard Macromolecular Mechanics (CHARMM) potential and has
the following contributions [69–71]:
Utotal = Ubond +Uangle +Udihedral +Uimpropers+UvdW +UCoulomb +UUrey−Bradley, (2.15)
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Where the Urey-Bradley term accounts for the angle bending using 1,3 non-bonded
interactions. Each of these interactions are given by
Ubond =
∑
bonds
Kb(b− b0)
2, (2.16)
Uangle =
∑
angle
Kθ(θ − θ0)
2, (2.17)
UUrey−Bradley =
∑
Urey−Bradley
KU(u− u0)
2, (2.18)
Udihedral =
∑
dihedral
Kχ(1 + cos(nχ− δ)), (2.19)
Uimpropers =
∑
impropers
Kϕ(ϕ− ϕ0)
2, (2.20)
UvdW =
∑
i
∑
j>i
4ǫij
[(
σij
rij
)12
−
(
σij
rij
)6]
, (2.21)
UCoulomb =
∑
i
∑
j>i
qiqj
4πǫ0rij
, (2.22)
2.2.4 Limitations of molecular dynamics
The quality of MD simulation most importantly depend on the accuracy of the
interatomic potential and the extent of phase space sampled. The interatomic poten-
tial can be modified to obtain accurate results. However, in general the first step is
probably to validate the accuracy of the simulation by comparing reliable properties
or behavior of the system either with experimental, theoretical or previous simula-
tion values. For membrane simulations the surface area per lipid is one such reliable
property. In this work, Chapter 3 starts with validation of the simulation results by
comparing surface area per lipid values with previous experimentally obtained values.
The extent of phase space sampling depends on the length of the simulation. The
two major factors that affect simulation length are the size of simulation system and
the availability of the computational resources i.e. the physiological time. Although
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computers are becoming cheaper and faster there is a need for accelerated MD tech-
niques to efficiently sample the phase space, especially for large systems. Some of
these accelerated methods, steered molecular dynamics (SMD), metadynamics and
targeted molecular dynamics (TMD) are used in this work.
2.3 Steered molecular dynamics
In steered molecular dynamics the SMD atom or the center-of-mass of the atoms
to be steered is attached to a dummy atom via a virtual spring. The dummy atom
is then moved at a constant velocity (cv-SMD) or by applying a constant force (cf-
SMD). SMD can therefore be used to apply external steering forces to drive the
reaction coordinate along a predetermined or hypothesized reaction path. The force
between the SMD atom and the dummy atom is the negative gradient of the potential
energy given by
U =
1
2
k[νt− (~r − ~r0) · ~n]
2 (2.23)
The potential of mean force (PMF) is the free energy profile along the reaction coordi-
nate and is important to determine conformational equilibrium properties of proteins
or transition rate of dynamical processes. The PMF is an equilibrium property while
steering in an SMD simulation is a non-equilibrium process. Therefore the Jarzynski’s
equality, which is an exact relation between the free energy differences and the work
done through non-equilibrium process is often used.
e−βδG = 〈e−βW 〉 (2.24)
Where, β = 1
kBt
, G is the Gibbs free energy, T is the temperature and W is the total
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work done to pull the SMD atom. The work W can be calculated by integrating the
total force over the SMD trajectory obtained using a sufficiently stiff spring. Potential
of mean force (PMF) calculations were made using the Jarzynki’s equation that was
generalized for isobaric-isothermal systems. These trajectories can be repeated to
reduce the statistical error of the calculated PMF. In this work we used the second
order cumulant expansion of the Jarzynski’s equality to calculate the PMF. The
second order cumulant is given by:
∆F = 〈W 〉 −
1
2
β(〈W 2〉 − 〈W 〉2) (2.25)
where W is the work performed, β = 1/kBT , kB is Boltzmann’s constant, T is the
bulk temperature, and ∆F is the free energy difference.
SMD is used in the Chapter 3 to steer a carbon nanotube through a lipid bilayer to
simulate lipid mechanical destabilization of lipid membranes. In Chapter 5, SMD is
used to steer a membrane spanning domain of HIV-1 gp41 into lipid bilayers to model
membrane spanning domain-lipid bilayer systems. SMD is also used in Chapter 6 to
model the pre-fusion intermediate of the gp41 ectodomain from a model of a six-helix
bundle, where the C-terminal heptad repeats of the ectodomain were steered to create
an extended ectodomain.
2.4 Metadynamics
In metadynamics, system forces in the MD simulation are augmented by those
arising from a history-dependent potential, which induces uniform sampling (i.e,
overcomes free energy barriers) along a specified collective variable (CV) [72–77].
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Following Laio et. al., we used the following external potential:
Vmeta(ξ) =
t′<t∑
t′
W
Ncv∏
i=1
exp
{
−
[ξi − ξi(t
′)]2
2δ2ξi
}
(2.26)
where ξi is the value of the CV, ξi(t
′) is the value of ξi at time t
′ from the atomic
coordinates, W is the Gaussian height, δξ is the Gaussian width and t
′ are the number
of MD steps between every Gaussian deposited. The metadynamics potential, when
converged, also provides a good estimate of the inverse free energy as a function of the
CV. Metadynamics in various forms has recently been applied for efficient conforma-
tional sampling and developing free energy profiles in various protein systems [77–82].
Metadynamics is used in Chapters 4 and 5 to study conformations of the membrane
spanning domain of HIV-1 gp41 in water and lipid environments respectively.
2.5 Targeted molecular dynamics (TMD)
In targeted molecular dynamics, an initial conformation of a system can be driven
to a target conformation through the application of a time-dependent restraining
force [83]. The method requires identification of TMD atoms in the system. At each
timestep, a steering force is applied on each atom by the potential
UTMD =
1
2
k
N
[RMSD(t)− RMSD∗(t)]2 (2.27)
Where, RMSD(t) is the instantaneous best fit RMSD of the current structure
from the target structure and RMSD∗(t) evolves linearly from the initial RMSD to
the target RMSD. Also, k is the spring constant and N is the number of TMD atoms
in the system.
TMD is used in Chapter 6 to drive a model built initial pre-fusion intermediate
structure of the HIV-1 gp41 ectodomain to a target six-helix bundle.
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2.6 Software and resources used
All trajectories in this work were performed using NAnonscale Molecular Dy-
namics (NAMD) versions (2.6 - 2.7b2) [84, 85]. Visual Molecular Dynamics (VMD)
(versions 18.6 - 1.8.7) software was used to visualize and analyze the trajectories.
VMD was also used to solvate membranes and proteins and to add counter ions to
the system.
The Protein Data Bank (PDB) was used to obtain some of the protein structures
used in this work. The PDB is avaialble as http://www.pdb.org/pdb/home/home.do
and is repository for several thousands of biomolecular structures.
The CHARMM-GUI membrane builder plugin was used to generate initial struc-
tures of the lipid bilayers used in this work. The obtained structures were then
minimized and equilibrated using NAMD.
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Chapter 3: Mechanical destabilization of a cholesterol containing lipid
bilayer
3.1 Introduction
Cholesterol rich detergent resistant domains (DRMs) present in the plasma mem-
brane of eukaryotic cells have been the focus of various research studies recently [20].
One of the important observations about these DRMs is that they likely act as plat-
forms for viral entry [86–89]. Enveloped viruses are also thought to bud from the
cholesterol rich domains present in the host-cell plasma membrane. Viral membranes,
including that of HIV-1, were observed to contain a higher cholesterol/phospholipid
ratio than that present in the plasma membrane of the host-cell. Although the exact
mechanism of viral entry is still unclear, it is understood that destabilization of both
the viral and target-cell membranes is necessary for successful infection. After bind-
ing to the receptor CD4 and the coreceptors CCR5/CXCR4 the hydrophobic glycine
rich fusion peptide of HIV-1 gp41 is exposed and is inserted into the target cell mem-
branes initiating membrane destabilization while anchoring gp41 in the target-cell
membrane. Theefore, studying the forces and free energies of rupture of lipid mem-
branes and the effect of cholesterol on them provides an understanding towards their
role in viral entry and as a source for viral envelope.
The purpose of this chapter is (i) to compare and validate the various membrane
properties calculated from molecular dynamics with those observed in experiments
and to study the effects of cholesterol content on those properties, and (ii) to calculate
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and compare the forces and free-energies of mechanical rupture, by inserting a highly
non-polar pristine carbon nanotube, of pure phospholipid bilayer with that of choles-
terol/phospholipid complexes. We calculated the surface are per lipid, membrane
thickness and membrane fluidity as given by the lipid order parameter (Scd), mem-
brane properties that are sensitive towards simulation parameters and are generally
thought to provide a reliable measure of the accuracy of lipid membrane simula-
tions [90]. We observed a good agreement between the values calculated from our
simulations and those obtained from experiments and the condensing and thickening
effects of cholesterol on a lipid membrane. Calculating the forces and free-energies of
insertion also suggested that the presence of cholesterol does not influence the force
of insertion, however bilayers containing 30% cholesterol had a higher free-energy of
rupture and likely assisted in membrane anchoring of the nanotube and membrane
destabilization.
3.2 Simulation methods and models
The simulation system consisted of a lipid bilayer, water and a carbon nanotube.
Lipid bilayers consisting of pure 1-palmitoyl-2-oleoyl-phophatidylcholine (POPC) and
with 10%, 30% and 50% cholesterol were prepared using the CHARMM-GUI mem-
brane builder. POPC was used because of it ubiquitous presence in host-cell mem-
branes [18, 91]. The bilayers consisted of a total of 200 lipid molecules and were fully
hydrated with approximately 39 water molecules per lipid. All simulations were per-
formed using NAMD version 2.6 and visualized using VMD v1.8.6. The CHARMM
force field and explicit TIP3P water was used. The simulation systems were initially
minimized for 10000 steps. Following minimization the systems were equilibrated in
the NPT ensemble for at least 5 ns. Surface area per lipid, membrane thickness and
the lipid order parameters were calculated for the last 3 ns of the simulation.
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Figure 3.1: Representative system of lipid membrane, carbon nanotube and water system prior to
nanotube insertion.
3.2.1 Order parameter
Lipid order parameters provide a measure of the fluidity of the lipid tails [18]. It
is generally given by a second order Legendre polynomial function expressed as
SCD =
1
2
(3 cos2(θi)− 1) (3.1)
where θi is the angle between the membrane normal and the bond between Ci and
C(i−1). The order parameter gives values of SCD = 1 when the tails are parallel to the
membrane normal and SCD = -0.5 when the tails are perpendicular to the membrane
normal. However, SCD can be 0 both when there is a very fluid random motion of
the lipid tails groups or when they are all aligned at an angle of 54.7◦.
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3.2.2 Membrane destabilization simulations
Carbon nanotube insertion simulations were performed only on pure POPC bilayer
and bilayers with POPC and 30% cholesterol based on the composition of target-cell
plasma membranes. The carbon nanotube was prepared to represent the dimensions
of a viral fusion peptide and was 20 A˚ length and approximately 12 A˚ in diameter.
Constant velocity steered molecular dynamics was used to steer the nanotube along
the membrane normal. The center-of-mass of the nanotube was used as the SMD atom
and the lateral degree of freedom of the nanotube were restricted using a force of 10
kcal/(mol*A) to avoid nanotube rotation or diffusion along the plane perpendicular
to the membrane normal. A sufficiently stiff spring constant of 7 kcal/mol/A was
used. The work done and the PMF were calculated as described in section 2.3.
3.3 Results
3.3.1 Membrane properties
Membrane structural properties for pure POPC and POPC/cholesterol bilayers
are given in Table 3.1. The surface area per lipid was found to be 62.46±2.03 A˚2
for pure POPC. The area per lipid for pure POPC was found to be 63 A˚2 exper-
imentally [1]. The area per lipid and the % area condensation values obtained at
different cholesterol content also compare well with previously reported experimental
values [1]. The surface area per lipid decreased with increasing cholesterol content
likely due to the condensing effect of cholesterol. Conversely, the membrane thickness,
calculated as the average distance between the phosphorous atoms of the exoplasmic
and the endoplasmic lipid head groups, increases with increasing cholesterol content.
Thickness of a pure POPC bilayer was found to be 38.07±0.87 . Addition of 10%
cholesterol showed the maximum increase in membrane thickness.
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Table 3.1: Membrane structural properties, surface area per lipid and membrane
thickness, obtained from 3 ns MD runs. *Surface area per lipid compared with ex-
perimentally observed values [1]
%Chol Sim. area Expt. area % Area. Thickness
(A˚2) (A˚2)∗ condensation A˚
0 62.46±2.03 63 0 38.07±0.87
10 58.22±2.65 58 6.78 40.04±1.34
30 51.33±1.90 48 11.83 40.70±1.35
50 48.35±1.94 44 5.81 41.20±1.19
The lipid order parameters (scd) for the sn-1 and sn-2 chains are given in Fig. 3.2.
The sn-1 chain in general had a high order parameter in the upper chain region and
had a higher disorder lower in the acyl chains due to availability of higher free space
for motion. The addition of cholesterol increased the overall order of the sn-1 chain,
although the increase is minimal between 30% and 50% cholesterol content. The
ordering effect of cholesterol is highers between C5 and C14 the region where the
fused rings of cholesterol are present. The sn-2 chain in POPC is monounsaturated
and the double-bond is present between C9 and C10. The portion of the sn-2 chain
close to the glycerol backbone is rigid and almost parallel to the membrane surface
and therefore has a lower order parameter. Cholesterol had minimal effect on the
sn-2 chain except at a high concentration of 50%. In general the order parameter
values are in good agreement with experimental values in the lower portion of the
acyl chains. The upper chain region of the sn-1 chain had a dip near C3 in the
experimental values which was not reproduced in our simulations [92].
3.3.2 Membrane rupture force and effects of cholesterol
To study the effects of mechanical rupture of a pure POPC bilayer with a carbon
nanotube we initially pulled the nanotube at three different velocities of v = 0.1
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A˚/ps, 0.05 A˚/ps and 0.01 A˚/ps using constant velocity SMD and calculated the
forces required to pull the nanotube using equation 2.23. Forces-Distance curves
were plotted as a function of the distance traveled by the dummy atom(-z) as the
nanotube traverses across the membrane. The magnitude and the profiles of the
force-distance curves depended upon the CNT velocity (Fig. 3.3).
The highest insertion forces decreased from 3612.26 pN to 1428.12 pN between
nanotube velocities of 0.1A˚/ps and 0.01 A˚/ps respectively. Immediately after pene-
tration of the lipid head groups the insertion force decrease as the nanotube enters
into the hydrophobic core of the membrane. At the two higher velocities the force
continued to decrease as the nanotube enters the endoplasmic leaflet of the membrane
before exiting the membrane. However at the lowest velocity of 0.01 A˚/ps the force
remained constant at approximately 800 pN following penetration.
To test the effect of cholesterol on membrane rupture the insertion simulations
were performed at the lowest velocity of v = 0.01 A˚/ps on a bilayer with 30 %
cholesterol content. The highest force of insertion was observed to be 1376.74 pN
and is lesser that that observed for a pure POPC bilayer. Comparing the two force-
distance profiles at v=0.01 A˚/ps for pure POPC and POPC with 30% cholesterol,
the force of insertion decreased with increasing cholesterol content. However, as the
nanotube exits the endoplasmic leaflet of the bilayer a second peak of 1268.44 pN
was observed (Fig. 3.4). The nanotube was also observed to destabilize the bilayer
by pulling the lipid molecules out of the endoplasmic leaflet of the membrane that
increased in the presence of cholesterol. In a pure POPC bilayer the nanotube removed
approximately 2 lipids when pulled out of the membrane, while in the presence of
cholesterol it increased to approximately 11 lipids molecules. The change in surface
area values presented in table 3.2 were computed as a function of the amount of free
space on the bilayer surface due to the removed molecules.
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Table 3.2: Free energy of insertion of nanotube into bilayers with and without choles-
terol. % change in surface area per lipid in term of number of lipid molecules deleted
by the nanotube
%Lipids CNT vel. Free-energy % change in
(A˚/ps)∗ (kcal/mol) surface area
POPC 0.01 35.74±3.54 2.07
POPC: 0.01 50.02±4.73 13.50
30%Chol
3.3.3 Free energy of membrane rupture
Since the applicability of Jarzynski’s equality requires reversibility of the process,
the free-energy calculations were performed only at the lowest velocity of v=0.01A˚/ps.
Since the nanotube disrupts the membrane as it exits the endoplasmic leaflet it dis-
rupts the membrane by pulling lipid molecules out of the membrane, we calculated
the rupture free-energies as a function of the work required for the nanotube to be
embedded in the membrane core. At the lowest velocity of 0.01 A˚/ps the free-energy
of insertion into a pure POPC bilayer was observed to be 35.74±3.54 kcal/mol. For
the bilayer with 30% cholesterol the free-energy of insertion increased to 50.02±4.73
kcal/mol.
3.4 Discussion
The surface area per lipid is a membrane property that can be used to validate
the accuracy of membrane simulations [90]. The surface area per lipid values for
both pure POPC and cholesterol containing bilayers obtained from our simulations
compare well with experimental values. The effect of cholesterol on the area conden-
sation and the thickening of the lipid bilayer was obvious with the obtained area per
lipid and membrane thickness values. The area per lipid decreased almost linearly
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with the cholesterol concentration until 30% cholesterol. However, the membrane
thickness had maximum increase at 10% cholesterol content and the percent change
in thickness decreased with increasing cholesterol between 10% and 50% cholesterol
content. The stiffening effect of cholesterol was also observed on the lipid order in
the bilayers. The order of both the sn-1 and sn-2 chains increased with increasing
cholesterol content. The interatomic potential could accurately reproduce the order
parameters in the lower portion of the lipids tails. However, the CHARMM potential
was slightly inaccurate in reproducing the experimentally observed order parameter
in the upper portion of the lipid acyl chains and it was corrected in a recent version
of the potential [93].
We further computed the forces and free-energies of insertion of a non-polar carbon
nanotube into a pure POPC and POPC with 30% cholesterol bilayers. To penetrate
the lipid bilayer it should create hydrophobic defect in the bilayer thereby exposing
the hydrophobic tail groups to water. The energy required to porate the membrane
depends on the interplay between the curvature and hydrophobic defects of the mem-
brane [53]. Previous coarse grained simulations have shown that as the nanotube
approaches the lipid bilayer the applied force becomes negative [94]. This could be
because of the “smooth” potentials used in coarse graining techniques. However, it
should also be noted that the velocity of nanotube penetration in this study is higher
and induces a negative curvature in the lipid bilayer thereby increasing the applied
force. Therefore the mechanism of nanotube penetration into the exoplasmic mono-
layer probably depends on the velocity of CNT. At lower velocities the lipid head
groups have more time for lateral movement and let the nanotube into the membrane
core and relieve the hydrophobic mismatch. This is probably also the reason for ob-
servable higher forces of penetration in simulations than in experiments. Similarly,
the penetration force was also observed to increase with the velocity in our simula-
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tions. However, in all cases the highest force was observed as the nanotube penetrates
the lipid head groups. This phase was followed by a steep lowering of the applied
force as the nanotube enters the hydrophobic core of the membrane. After the nan-
otube enters the membrane the hydrophobic mismatch between the lipid molecules
and the nanotube results in the lipid tails wrapping the nanotube to reduce the unfa-
vorable exposure of the hydrophobic core to water thereby reducing the pulling forces.
The force-distance profiles are however different following internalization for different
pulling velocities of the nanotube. A non-polar nanotube would partition into the
hydrophobic core of the lipid bilayer under no applied external force [95]. Therefore,
a second peak could be observed between 60 A˚ and 70 A˚ as the nanotube exists the
membrane at a velocity of 0.05 A˚/ps as it penetrates the head groups of the lower lipid
monolayer. Also, blocking of the lipid molecules and the strong interactions of lipids
in close proximity of the nanotube probably resulted in an increased force. However,
at the highest velocity of 0.1 A˚/ps although a second peak can be observed the ap-
plied force is too high for these interactions and therefore less membrane deformation
was observed. At the lowest velocity of 0.01 A˚/ps more lipid molecules were inter-
acting with the CNT and were removed along with the nanotube and therefore there
was no observable increase in force. Blocking of nanotube by lipids, especially those
from the lower leaflet, was previously observed in simulation studies [94]. Therefore
poration forces depend on the energies involved in the membrane bending, breaking
of the hydrogen bonds between the head groups and water molecules, the hydrophilic
interactions between the lipid head groups, the hydrophobic interactions between the
nanotube and the lipids and the energy required for the lateral movement of the lipid
molecules. Besides the friction between the nanotube and the membrane lipids also
plays an important ole in the total force.
To estimate the effect of cholesterol on the forces and required for nanotube pen-
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etration, we tested our method on lipid bilayer with 70% POPC and 30% cholesterol
with a nanotube velocity of 0.01 A˚/ps. A comparison of the obtained force-distance
profile with that of pure POPC bilayers (Fig. 3.4) showed a much reduced observed
membrane bending. However, the force required to puncture the membrane remained
similar to pure POPC bilayers. Although the presence of cholesterol stabilizes the
bilayer, cholesterol also partitions into the spaces between the lipid molecules and
therefore induces a spontaneous negative curvature on the bilayer. Further an ob-
servable second peak was observed as the nanotube exits the bilayer and the force
required for the nanotube to exit the bilayer was also higher than for pure POPC.
It was also observed that as the nanotube exits the bilayer, higher number of lipids
were extracted from the bilayer containing 30% cholesterol than pure POPC thereby
disrupting the bilayer. Therefore, the presence of cholesterol likely stiffens the mem-
brane and makes it relatively “brittle” compared to a pure POPC bilayer, leading to
greater destabilization of the membrane.
The free energy required for nanotube insertion into the bilayer was found to be
35.74±3.54 kcal/mol. This estimate is slightly lesser than to the amount required to
porate a lipid monolayer which was expected to be 40-55 kcal/mol [53]. The energy
released in relieving the membrane curvature defect probably facilitates nanotube
internalization into the polar head groups of the membrane. After the nanotube
across the energy barrier, the non-polar nanotube is spontaneously internalized by
the hydrophobic lipid tails and the PMF decreases. Following this phase the PMF
should be expected to have a minimum at the center of the bilayer.
In the presence of 30% cholesterol, the free energy of rupture increased to approx-
imately 50 kcal/mol. The formation of two to three extended coiled coils required
to porate a cell membrane by viruses was estimated to provide 60-90 kcal/mol of
energy. However, it should be noted that the amino acid sequence of the viral fusion
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peptides and the composition of the lipid bilayers also play an important role in de-
termining the forces required and the energetics of membrane rupture during viral
infection. In the absence of external applied force on the nanotube there would prob-
ably be minimal membrane bending and the mechanism of internalization depends
only on the hydrophobic mismatch. This would probably explain the spontaneous in-
ternalization of carbon nanotube with small diameters. However, for the nanotube to
traverse across the bilayer a two-phase internalization mechanism involving an energy
requiring step is needed to cross the saddle point at the endoplasmic head groups.
3.5 Conclusions
In this work we calculated membrane structural properties of pure POPC bilayers
and POPC/cholesterol complexes using molecular dynamics. The obtained surface
area per lipid, membrane thickness and lipid order parameter compared well with ex-
perimentally observed results [1, 92]. The lipid order parameter calculations, however,
could only reproduce the order parameters for the lower portion of the acyl chains.
We further used a non-polar carbon nanotube as a nanosyringe to test the rupture
forces and free-energies of the bilayers. These results suggested similar rupture forces
for bilayer with and without cholesterol. However, the free-energy required to cross
the lipid head groups increased in the presence of cholesterol. Also, the presence
of cholesterol resulted in higher destabilization of the membrane as the nanotube is
pulled out of the hydrophobic core of the membrane.
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Figure 3.2: Order parameter profiles for the sn-1 (left) and sn-2 (right) acyl chains
of POPC with varying cholesterol content. Pure POPC (black), POPC:10%Chol(red),
POPC:30%Chol(green),POPC:50%Chol(blue)
35
Figure 3.3: Force-distance profiles of pure POPC (blue) and POPC:Cholesterol bilayer with 30%
cholesterol (red) obtained at a nanotube velocity of v = 0.01 A˚/ps
Figure 3.4: Force-distance profiles of pure POPC (blue) and POPC:Cholesterol bilayer with 30%
cholesterol (red) obtained at a nanotube velocity of v = 0.01 (A˚
/ps
36
Chapter 4: HIV-1 gp41 membrane spanning domain structure in water
4.1 Introduction
The HIV-1 membrane spanning domain anchors the Env in the viral membrane.
The MSD is a highly conserved region of gp41, spanning 27 residues from Lys681 to
Arg707 and contains a mid-span charged residue Arg694 [50], a common feature of
lentiviral MSD’s(Fig. 4.1) [96, 97]. The MSD also contains a GXXXG motif between
residues 688 and 692. Although GXXXG motifs are thought to be involved in inter-
helical interactions [98, 99], the loss of these residues does not affect the trimerization
of the Env monomers required during transport from the endoplasmic reticulum to
the Golgi apparatus [50]. However, loss of Arg694, the GXXXG motif or the charged
residues Lys681 and Arg705 affect membrane fusion and viral infectivity [49, 50, 97,
100–102].
Despite the MSD’s importance in viral infectivity, the absence of X-ray crystal-
lographic or NMR structural information resulted in minimal information about its
structure and function at the atomic level. However, based on it sequence the MSD
likely assumes an α-helical conformation in the viral membrane. In this chapter we
model build MSD based on its sequence using a α-helical subdomain of viral protein
Vpu. We further investigate the structure of MSD in water using all-atom simulations.
However, classical molecular dynamics simulation is likely insufficient for sampling all
relevant protein conformations due to computational limitations. We therefore used
metadynamics to accelerate conformational sampling of MSD and we predict con-
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Figure 4.1: Schematic of HIV-1 gp41 membrane spanning domain. The basic residues are shown
in blue, polar residues in green and non-polar residues in silver
formations lowest in free energy. We demonstrate that the MSD shuttles between a
stable kinked conformation and a metastable “loop” conformation in solvent water.
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4.2 Simulation description
4.2.1 General
All simulations were performed using NAMD 2.7b1 with the CHARMM force
field and explicit TIP3P water [84, 103, 104]. VMD 1.8.7 was used for visualization
and preparation of the simulation systems [85]. All production runs were performed
in the NVT ensemble unless explicitly specified using a Langevin thermostat at a
temperature of 310K with a coupling constant of 5 ps−1.
4.2.2 Gp41 MSD model
HIV-1 gp41 MSD (681-KLFIMIVGGLVGLRIVFAVLSIVNRVR-707) is a 27 amino
acid peptide thought to span the bilayer as an α-helix based on sequence [49–51]. We
modeled gp41 MSD from a 27 amino acid helical subdomain of the HIV-1 Vpu protein.
The side-chain atoms of the Vpu subdomain were deleted and replaced with those of
the HIV-1 gp41 MSD. The obtained MSD structure was then solvated with 14,647
water molecules, neutralized and brought to an ionic strength of 0.1 M by adding
Na+ and Cl− ions and was volume equilibrated for 100 ps in the NPT ensemble. This
system was then equilibrated for a total of 20 ns in the NVT ensemble.
4.2.3 Metadynamics
A detailed description of metadynamics is given in section 2.4. For this study the
root-mean-squared displacement of the backbone (C, Cα, N, O) atoms with respect
to those in a perfect α-helix (RMSDα) was chosen as the CV. We used W = 0.15
kcal/mol, δξ = 0.01 A˚, and deposited a new Gaussian every 1 ps. A low RMSDα on
the free energy profile indicates a helical conformation, while kinks and unfolding of
the peptide occur at relatively larger RMSDα.
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We performed two 120 ns metadynamics simulations starting from two different
initial conformations obtained from the 20 ns MD simulation with the MSD solvated
in water, (i) an α-helical conformation with RMSDα less than 1 A˚ and (ii) a stable
kinked conformation with RMSDα 6 A˚. A repulsive wall with a force constant of 500
kcal/mol was used at 14 A˚ for the run starting from α-helical conformation and at
12 A˚ for the run starting from the kinked conformation. The CV profile during the
course of the two simulations shows sampling of the CV space between 0 A˚ and the
upper wall (Fig. 4.3). The free energy profiles between CV space of 0 and 10 A˚ were
considered converged and the RMSDα CV extensively sampled conformations during
these simulations. Metadynamics calculations at RMSDα higher than 10 A˚ resulted
in unfolding of the MSD peptide and are not thoroughly sampled by the RMSDα CV
with respect to a perfect α-helix and therefore are not reported in this work.
4.3 Results
Figure 4.2: RMSDα of the MSD in pure water with respect to the initial α-helical conformation
vs. simulation time during 20 ns of MD
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4.3.1 HIV-1 gp41 MSD structure in water from molecular dynamics sim-
ulations
We tested the stability of the α-helical structure of gp41 MSD solvated in water
using molecular dynamics. The RMSDα evolution from a 20 ns MD is shown in
Fig. 4.2. These data suggest a stable conformation of the peptide between RMSDα 5
and 6 A˚. However, after 5 ns the MSD assumes a conformation with a higher RMSDα
between 7-9 A˚. Similar behavior was observed after about 18 ns of MD simulation for
the final 2 ns. The α-helical structure was observed to be highly unstable and therefore
the MSD immediately kinked within 1 ns at Val691 during the MD run. This kink is
a result of water molecules interacting with the glycine residues and destabilizing the
backbone hydrogen bonds while the peptide minimizes the exposure of hydrophobic
surface area to water. However, the hydrogen bond between Arg694 and Leu690 was
intact even after helix bending. Although the GXXXGmotif unfolded to facilitate Gly
interactions with water molecules, the rest of the MSD remained helical. The bulky
arginine side chains and the phenylalanine side chain along with the kink minimize the
protein backbone atom interactions with water molecules between residues 692 and
707. The two unstable high-RMSDα structures occur due to the occasional breaking
of intrahelical hydrogen bonds between Leu690-Arg694 and Arg694-Ala698. This results
in a loop-like conformation with RMSDα between 7-9 A˚. However, a 20 ns MD run is
probably insufficient to unfold a helical peptide and sample all relevant conformations.
4.3.2 MSD structure in water from metadynamics
To accelerate conformational sampling of the MSD two 120 ns metadynamics tra-
jectories were started from different conformations of the peptide randomly selected
from the initial MD run, one from a α-helical structure and another from the kinked
structure. The RMSDα was the CV. The CV trace during the course of the simulation
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Figure 4.3: CV profiles of two 120 ns metadynamics runs with gp41 MSD in pure water starting
from a complete α-helical conformation (red) and a kinked conformation (green)
suggests a thorough sampling of CV space (Fig. 4.3).
Figure 4.4: Free energy profiles from two metadynamics runs with gp41 MSD solvated
in pure water starting from an α-helical conformation (red) and a kinked conformation
(green). Average free energy from both the runs is shown in blue.
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The free energy profiles from the two runs and the average are presented in Fig. 4.4.
This free energy profile suggests a very stable conformation that has a single kink at
the GXXXG motif between 4-6 A˚ RMSDα. The free energy profile also shows that the
conformations between 8-10 A˚ RMSDα, although metastable, can be accessed only by
overcoming a few kcal/mol free energy barrier. These results support the conforma-
tions observed during our initial MD run as in a stable kinked helix at the GXXXG
motif and a metastable structure with a second kink at Phe697. Furthermore, the free
energy profile also suggests a metastable α-helical structure in water. These results
indicate that the residues C-terminal to Arg694 can form a stable α-helical structure
even in water and that the residues N-terminal to Arg694 kink at the GXXXG mo-
tif. However, it should be noted that with water as solvent and the polar residues
accessible, most of the helical structure remained intact, despite the kink.
4.4 Discussion
Figure 4.5: Representations of stable kinked conformation (left) and metastable loop conformation
of MSD (right) of gp41 MSD in pure water observed in 20 ns MD simulation
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During the 20 ns MD run the α-helical MSD immediately (< 2 ns) assumed a
kinked conformation in water. The RMSDα evolution of the MD simulation suggested
that the MSD shuttles between a stable conformation between 4-6 A˚ RMSDα and a
metastable conformation (Fig. 4.2). The kink in the stable conformation was observed
at the GXXXG motif. In the metastable state the MSD assumed a “loop” structure
with one kink at the GXXXG motif and a second kink at Phe697 (Fig. 4.5). The stable
kinked conformation was previously observed during short (< 4 ns) MD simulations
of MSD. However, to our knowledge we are first to report the “loop” conformation of
the MSD in water. Therefore, we performed metadynamics simulations starting from
two different initial configurations to obtain the PMF profile of the MSD in water.
The average PMF profile obtained from the two 120 ns metadynamics simulations
corroborated the observations from the MD simulations. The PMF profile had a
minimum between 4-6 A˚ RMSDα suggesting a stable conformation in that region.
The PMF profile also suggested multiple metastable conformations between 8-10 A˚
RMSDα that are accessible across a low energy barrier from the stable conformation.
The structures of MSD observed in the stable and metastable regions of the PMF
profile are similar to the kinked and loop structures observed during the MD run
respectively. The obtained PMF profile also suggested highly metastable completely
α-helical conformation that explains the fast conformational change from a α-helix
to the kinked conformation during the MD run. It should however be noted that
in a MD simulation the MSD could still sample in the α-helical conformation for
longer time but it is unlikely that a kinked or loop conformation would assume a α-
helical conformation. The CV profiles obtained from metadynamics however showed
a thorough and extensive sampling of the conformational space.
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4.5 Conclusions
In this chapter, we model built an all-atom structure of MSD using its sequence
and an α-helical subdomain of the viral protein Vpu. We further sampled confor-
mations of MSD in water using both molecular dynamics and metadynamics and
reasoned that although the MSD assumes a stable kinked structure in water, it can
shuttle among the stable conformation and several metastable conformations.
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Chapter 5: HIV-1 gp41 membrane spanning domain structure in
cholesterol containing lipid membranes
5.1 Introduction
Human immunodeficiency virus (HIV) entry into the target cells is mediated by
trimeric complexes or “spikes”, comprised of glycoprotein heterodimers. Each het-
erodimer is a non-covalently linked complex of receptor-targeting gp120 and membrane-
anchoring gp41. Beginning at its N-terminus, gp41 is comprised of a glycine rich
fusion peptide (FP), the so-called N- and C-terminal heptad repeats (NHR and CHR
respectively), a membrane-proximal external region (MPER), a membrane-spanning
domain (MSD) and a long cytoplasmic tail that extends into the endoplasmic side
of the viral lipid bilayer envelope. When spike-associated gp120 binds to its target
CD4 receptor, it undergoes conformational changes that (i) decrypt a binding site
for CCR5/CXCR4 receptors and (ii) initiate a cascade of conformational changes
in gp41 [8, 9, 41–45]. These changes are thought to include insertion of previously
spike-sequestered FP’s into the target cell membrane and eventual refolding of the
NHR/CHR’s to form a so-called six-helix bundle (6HB) which pulls the viral and
cell membranes together in preparation for fusion [48]. Although this “pull-model”
of membrane fusion is theoretically appealing, it does not address the experimentally
observed behavior of certain gp41 mutants, especially those that strengthen the inter-
action of gp41’s MSD with the viral membrane while compromising infectivity [50].
We speculate that a major functional role of gp41 is to destabilize the viral membrane
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as a necessary part of the fusion mechanism.
For the entire MSD to span the viral membrane, Arg694 localizes to the hydropho-
bic core, which is energetically unfavorable compared to being solvated by water.
However, residues such as arginine, when required by sequence to be inside a lipid
membrane, “snorkel”; i.e. the charged end groups of the side chains localize to the
hydrophilic head-groups of one membrane leaflet [105].
The purpose of this study is to understand the structure and orientation of MSD
in a cholesterol containing lipid membrane and the effects of MSD conformation
on the viral membrane structure in order to provide clues toward an explanation
of the functional roles of conserved MSD features. Recent simulation studies using
molecular dynamics suggested that the MSD assumes an α-helical conformation in a
lipid membrane [51]. We used metadynamics to accelerate conformational sampling
of MSD, and we predict conformations in membrane-spanning states lowest in free
energy. In particular, we demonstrate the effects of Arg694 and snorkel direction of
the Arg694 side-chain on water penetration to the membrane core and local membrane
thinning.
5.2 Simulation description
5.2.1 General
All simulations were performed using NAMD 2.7b1 with the CHARMM force
field and explicit TIP3P water [84, 103, 104]. VMD 1.8.7 was used for visualization
and preparation of the simulation systems [85]. All production runs were performed
in the NVT ensemble unless explicitly specified using a Langevin thermostat at a
temperature of 310K with a coupling constant of 5 ps−1.
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5.2.2 Gp41-membrane model
We used steered molecular dynamics (SMD) to insert water-equilibrated α-helical
MSD into solvated lipid bilayers comprised of 50 mol% dipalmitoylphophotidylcholine
(DPPC)/cholesterol [87–89]. Two MSD-membrane simulation systems were prepared
(Fig. 5.1): (1) MSD inserted with Arg694 snorkeling towards the exoplasmic head
groups and (2) MSD inserted with Arg694 snorkeling towards the endoplasmic head
groups. The exoplasmic (N-terminal) and endoplasmic (C-terminal) sides of the mem-
brane are only based on the orientation of the MSD peptide in the bilayer and the
lipid and solution composition of the leaflets are similar.
Figure 5.1: Membrane-peptide models of MSD α-helix with Arg694 snorkeling towards exoplasmic
head groups (A) and endoplasmic head groups (B). (C) Structural conservation between the two
MSD models and the exoplasmic (red) and endoplasmic (blue) snorkeling positions of Arg694 after
20 ns of equilibration. The residues with the highest structural conservation are shown in blue and
the lowest are shown in red. The Leu mutant was prepared using the endoplasmic snorkeling model.
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The CHARMM-GUI membrane builder was used to generate initial bilayer struc-
tures containing 512 lipid molecules [106]. An initial MSD-membrane system was
prepared by placing MSD 35 A˚ above the lipid bilayer and the system was fully sol-
vated by adding explicit TIP3P water molecules. The simulation box measured 105
A˚ × 98 A˚ × 127 A˚ and contained a total of 141642 atoms with 512 lipid molecules,
29561 water molecules for complete solvation of the bilayer and MSD, and 280 Na+
and Cl− ions. The system was then equilibrated in the NPT ensemble for 6 ns.
Following equilibration, the MSD peptide was inserted into the lipid bilayer using
constant velocity SMD. To obtain the exoplasmic Arg694 snorkeling model, we used
the center-of-mass of Arg707 as the SMD atom and steered the peptide in the mem-
brane from the exoplasmic side of the bilayer with Arg694 interacting with the water
molecules and lipid head groups towards the exoplasmic leaflet. Similarly, to obtain
the endoplasmic Arg694 snorkeling model we used the center-of-mass of Lys681 as the
SMD atom and inserted the peptide from the endoplasmic side of the bilayer. For
both the models we used a steering velocity of 10 A˚/ns and the lipid head groups
were restrained in the z-direction to prevent bilayer distortion. Insertion of MSD into
the membrane to obtain the exoplasmic snorkeling model resulted in slight unfold-
ing of the helix near 696-698 and 704-707. Therefore, in the endoplasmic snorkeling
model the MSD secondary structure was restrained during insertion. However, both
the models showed a good structural conservation following a 20 ns MD equilibration
(Fig. S1C).
Following MSD insertion the simulation system was cropped by removing the ex-
cess water required to solvate MSD prior to insertion. Moreover, the lipid bilayer was
also cropped to reduce the system size while maintaining at least twice the theoretical
length of MSD (40 A˚) in the lateral dimensions. The simulation boxes measured 80
A˚ × 84 A˚ × 80 A˚ and 85 A˚ × 81 A˚ × 77 A˚ and the total number of atoms were
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58524 and 58185 for the exoplasmic and endoplasmic snorkeling models, respectively.
The final gp41-membrane models contained approximately 320 lipid molecules and a
32:1 water to lipid ratio to ensure complete solvation. The systems were then neu-
tralized and brought to an ionic strength of 0.1 M by adding Na+ and Cl− ions and
were equilibrated in the NPT ensemble for 3 ns followed by equilibration in the NVT
ensemble for at least 5 ns prior to the metadynamics calculations.
To create the Arg694 to Leu mutant, the membrane inserted and equilibrated
peptide from the endoplasmic snorkeling model was used. Arg694 was mutated to
Leu694 using Mutate Residue plugin in VMD. The obtained system was then further
equilibrated in the NPT ensemble for 3 ns and NVT ensemble for at least 5 ns.
5.2.3 Metadynamics
For this study the root-mean-squared displacement of the backbone (C, Cα, N,
O) atoms with respect to those in a perfect α-helix (RMSDα) was chosen as the
CV. For all metadynamics simulations, we used W = 0.15 kcal/mol, δξ = 0.01 A˚,
and deposited a new Gaussian every 1 ps. A low RMSDα on the free energy profile
indicates a helical conformation, while kinks and unfolding of the peptide occur at
relatively larger RMSDα. The arithmetic average of the free energy profiles in two 10
ns intervals after a certain filling time (tf ) were compared to judge the convergence
of metadynamics calculations (Fig. S8,S9). The filling time tf = 240 ns for the exo-
plasmic model and tf= 120 ns for the endoplasmic model after which the calculation
sampled the CV range diffusively. The free energy profiles between CV space of 0
and 10 A˚ were considered converged and the RMSDα CV extensively sampled con-
formations within this region. Metadynamics calculations at RMSDα higher than 10
A˚ resulted in unfolding of the MSD peptide and are not thoroughly sampled by the
RMSDα CV with respect to a perfect α-helix and therefore are not reported in this
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work.
5.3 Results
5.3.1 Effects of Exoplasmic snorkeling of Arg694 on MSD conformational
ensembles
A single 260 ns metadynamics simulation resulted in uniform exploration of CV-
space between 0-13 A˚ RMSDα, when initiated from a helical conformation in which
the Arg694 side chain snorkels towards the exoplasmic head-groups. The averaged free
energy profile for the last 10 ns computed using metadynamics is shown in Fig. 5.3.
Conformations with RMSDα between 1 and 2 A˚ display the lowest free energy. The
RMSDα visited helical and non-helical states several times through out the 260 ns
metadynamics calculation (Fig. 5.2).
The most stable conformation in this model is a complete α-helical conforma-
tion with Arg694 sidechain snorkeling to interact with the water molecules and lipid
head groups towards the exoplasmic leaflet. In this conformation, the peptide tilts
with respect to the membrane normal to facilitate Arg694 snorkeling while prevent-
ing water molecules to interact with the hydrophobic residues between 681 and 692
thereby stabilizing the α-helix. However, the proximity of Arg694 to the glycines in
the GXXXG motif results in water molecules interacting Gly688, Gly689 and Gly692.
Thermal fluctuations result in opening and closing of the backbone hydrogen bonds
in the α-helix and water molecules competing for the hydrogen bonds destabilize the
α-helical structure. Furthermore, the propensity of hydrophobic residues to localize in
the membrane core results in peptide bending at Val691. However, water interactions
with glycines result in the MSD eventually kinking at Gly692 and also unfolding of
the GXXXG motif, with the hydrophobic Leu690 and Val691 buried in the membrane
core and Gly688, Gly689 and Gly692 interacting with water. The free energy profile
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suggests metastable kinked conformations with RMSDα between 4 and 6 A˚.
Figure 5.2: CV trace during metadynamics calculations for MSD in lipid bilayer with Arg694
snorkeling towards the exoplasmic leaflet (red), the endoplasmic (green) leaflet and the Leu mutant
as a function of the simulation time
The metastable state has the Arg694 side-chain interacting with the exoplasmic
head groups and water molecules, with the MSD kinked at Gly692 and unfolding of
the GXXXG motif (Fig. 5.4). The rest of the peptide between residues 694 and 702
retains an α-helical structure in this conformation. However, the C-terminal residues
from 703 to 707 unfold to facilitate Arg694 snorkeling and thereby loss of a helical turn
at the C-terminus. Also, peptide conformations with a complete helical structure but
kinked at Arg694 were sampled at RMSDα of 4-8 A˚.
Unfolding of the subdomain between residues 681 and 694 is the combined re-
sult of hydrophobic localization in the membrane core, Lys681 snorkeling towards the
exoplasmic lipid head groups, and the presence of water molecules destabilizing the
helical structure. However, these conformations had a relatively high RMSDα (8-10
A˚) and as can be seen from the free energy profile are relatively unstable. Finally,
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we note that the Arg694 side-chain remained in interaction with the exoplasmic head-
groups throughout the calculation.
5.3.2 Effects of Endoplasmic snorkeling of Arg694 on MSD conformational
ensembles
Figure 5.3: Free energy profiles of MSD in a lipid membrane with Arg694 snorkeling towards
exoplasmic head groups sampled during 260 ns metadynamics (red), Arg694 snorkeling towards
endoplasmic head-groups sampled during 140 ns metadynamics run (blue) and Leu694 mutant (cyan).
Schematic illustration of MSD with basic charged residues in blue and polar residues in green.
Hydrophobic residues are shown in silver and Arg694 side-chain is shown in exoplasmic (red) and
endoplasmic (blue) snorkeling positions.
We conducted a second metadynamics calculation initiated from an α-helix with
the Arg694 side-chain snorkeling toward the endoplasmic head-groups. During this run
metadynamics sampled the CV space between 0 and 15 A˚ RMSDα again uniformly
and the simulation was stopped at 140 ns when the peptide completely unfolded
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(Fig. 5.2). The two predominant conformations in this model are (i) a completely
helical conformation, with RMSDα less than 2 A˚ and the axis of the α-helix tilting
with respect to the membrane normal to facilitate snorkeling of the Arg694 side chain
and (ii) a kinked helix, RMSDα 4-6 A˚, with the kink at Phe
697 and residues 681
through 697 spanning the bilayer along with the snorkeling side chains of Lys681 and
Arg694 (Fig. 5.4). Of these, the tilted α-helical conformation between RMSDα 0 to
2 A˚ is the more stable structure. In this conformation, Arg694 snorkels towards the
endoplasmic head groups and interacts with water molecules penetrating the lipid
bilayer. Arg705 positioned on the same side of the α-helix, near the C-terminus of
the MSD, assists in α-helix tilting by interacting with water molecules and lipid
head groups at the membrane-water interface. Moreover, Arg705 also interacts with
water molecules penetrating the membrane core towards Arg694. Interaction of Arg705
with both molecules at the membrane water interface and water molecules in the
membrane core with a “paddle” motion was also observed in the 20 ns MD simulation.
Therefore, in a completely α-helical conformation the presence of a charged residue
with a relatively large side chain assists in snorkeling of Arg694 by inducing helix
tilt and also acting as a mediator for water molecule penetration into the membrane
core. Furthermore, with two long side chains of Arg694 and Arg705 interacting with
the water molecules in the membrane core, the backbone hydrogen bonds between the
residues 694 to 705 were shielded from competition from water. A tilted, completely
α-helical MSD conformation was also favorable to the two charged residues, Lys681
and Arg707, on either terminus of the MSD. The long side chains of lysine and arginine
are also predominantly hydrophobic except for the charged moieties at the end. We
observed that in a tilted α-helix the N-terminus of the MSD was in the hydrophobic
membrane environment while the tip of the side chain snorkels and interacts with the
lipid head groups and water. Similarly, the tilt also pulled Arg707 relatively further
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into the membrane core where it could then snorkel and interact with molecules at
the membrane-water interface.
The set of conformations that were extensively sampled with approximately 4 A˚
RMSDα were very similar to the hypothesized snorkeling model proposed by Hunter
et. al. (Fig. 5.4) [49]. In this set, the presence of water molecules near the C-
terminal residues of the MSD, especially when Arg705 interacts with molecules at the
membrane-water interface, results in destabilization of the helix with loss of a hydro-
gen bond between Phe697 and Ser701. This results in the MSD α-helix bending at
Phe697, while the rest of the subdomain from 698 through 707 maintains an α-helical
conformation. Additionally, the hydrogen bond between Arg694 and Ala698 was main-
tained even after helix bending. The partitioning of the charged groups towards the
membrane-water interface and the hydrophobic groups towards the membrane core
assists in maintaining the α-helical conformation by protecting vulnerable backbone
hydrogen bonds from attack by water. Residues 681 through 697 spanned the bilayer
in this model with the two long side chains of Lys681 and Arg694 snorkeling towards
the exoplasmic and endoplasmic head groups respectively. These residues maintained
a helical structure with the hydrophobic part of the Arg694 side chain shielding the
hydrogen bonds between residues 694 and 697 from water molecules in the membrane
core. Although these conformations were sampled extensively by metadynamics, the
final free energy profile suggests that these conformations are metastable.
As seen in the case of exoplasmic Arg694 snorkeling, metadynamics sampled various
unstable and short lived conformations during endoplasmic Arg694 snorkeling simula-
tion. However, most of these conformations retained the α-helical structure between
residues 681 and 697. The presence of lipid head groups and water molecules at
the membrane water interface resulted in destabilization of the helical subdomain be-
tween 698 and 707. Conformations with a completely unfolded C-terminal subdomain
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were also observed. During this run we also observed a completely unfolded MSD
peptide. In these conformations the C-terminal charged residues and water molecules
associated with these residues entered deep into the lipid bilayer core resulting in the
interaction with GXXXG motif and destabilization of the backbone hydrogen bonds.
5.3.3 Effects of Arg694 to Leu mutation onMSD conformational ensembles
Metadynamics calculations with the Leu mutant were performed for a total of
170 ns and was initiated from an α-helix. Metadynamics extensively sampled the
CV space between 0 and 13 A˚ during this simulation. The simulation was stopped
when the peptide completely unfolded. The two major conformations sampled during
this run were a completely α-helical conformation with RMSDα less than 2 A˚ and a
kinked conformation with RMSDα between 4 and 6 A˚ and similar to the metastable
conformation observed in the endoplasmic snorkeling model. Similar to the other
two models the α-helical conformation is the stable conformation and the kinked
conformation is the metastable state as observed from the PMF profile (Fig. 5.3).
Although the conformations observed with the Leu mutant are similar to the endo-
plasmic snorkeling model, water penetration into the membrane was not observed due
to the lack of a polar side chain the hydrophobic core of the membrane. Moreover,
in the kinked conformation the axis of the subdomain between Lys681 and Phe697
was also not always parallel to the membrane normal as observed in the endoplasmic
snorkeling model. This is likely due to the absence of Arg694 stabilizing the subdo-
main by interacting with the endoplasmic head groups and water molecules. Water
molecules competing for the hydrogen bonds with the backbone were also observed
in the kinked conformation near Phe697. In the stable completely α-helical confor-
mation the helix tilt was observed likely due to the presence of Arg705 and also the
hydrophobic part of the Lys681 side-chain trying to be buried in the hydrophobic core
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while the tip interacts with the polar groups.
Metadynamics calculation also sampled several short lived conformations during
this run including a conformation with a kink in the GXXXG motif similar to the
exoplasmic snorkeling model. However, water molecules present in the vicinity prior
to the mutation and interacting with the backbone atoms during the metadynamics
run likely contributed towards the kink that was unstable and short lived. The
completely unfolded peptide at the end of the metadynamics run resulted in water
molecules entering into the core of the membrane as observed in the other two models.
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Figure 5.4: Representation of stable and metastable conformations of MSD in a lipid bilayer with
Arg694 snorkeling towards the exoplasmic, endoplasmic head groups and the Leu mutant.
58
5.3.4 Effects of MSD conformation on membrane thickness
Figure 5.5: (Upper panels) Map of mean membrane thickness (measured as a distance between
centers of mass of lipid head groups in 10 A˚ square sections of each leaflet); color bar units in A˚.
Left, stable; right, metastable. (Lower panels) Side-view snapshots of stable (left) and metastable
(right) conformations.
In Fig. 5.5, Fig. 5.6 and Fig. 5.7 we show plots of average membrane thickness for
the exoplasmic snorkeling model, endoplasmic snorkeling model and the Leu mutant
respectively of MSD in their stable and metastable states. The average bilayer thick-
ness of DPPC-cholesterol (50 mol%) was observed to be 45 A˚. Membrane thickness
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for the exoplasmic and endoplasmic snorkeling models was found to be significantly
lower (approximately 35 A˚) than pure DPPC-cholesterol bilayer thickness in the prox-
imity of the peptide in both the stable and metastable state. Exoplasmic snorkeling
Arg694 resulted in a localized membrane defect in the upper leaflet while endoplasmic
snorkeling of
Figure 5.6: (Upper panels) Map of mean membrane thickness (measured as a distance between
centers of mass of lipid head groups in 10 A˚ square sections of each leaflet); color bar units in A˚.
Left, stable; right, metastable. (Lower panels) Side-view snapshots of stable (left) and metastable
(right) conformations.
Arg694 results in a localized membrane defect in the lower leaflet due to water pen-
etration and lipid head groups interacting with Arg694. Although, the stable and
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metastable state of the endoplasmic snorkeling model displayed similar membrane
thickness, it was observed that the stable conformation of the exoplasmic snorkeling
model had lower average membrane thickness than the metastable state. It should be
noted that in the metastable state of the exoplasmic model the MSD unfolded near
the C-terminus to facilitate Arg694 snorkeling towards the exoplasmic head groups.
This condition is true for both the tilted completely α-helical conformations that
places Arg694 near the center of the bilayer and the metastable kinked conformations
in which the membrane spanning subdomains are relatively short. For conformations
with higher RMSDα in both the models, unfolding of the peptide resulted in charged
groups at the termini burying themselves in the hydrophobic core of the bilayer.
These conformations resulted in significant water penetration into the membrane.
Conversely, the Arg694 to Leu mutant displayed a membrane thickness similar to
pure DPPC bilayers in the stable α-helical conformation. In the metastable state
the kink at Phe697 combined with the polar residue interacting with water and head
groups at the terminals resulted in minimal decrease in membrane thickness.
5.4 Discussion
In our model with Arg694 snorkeling towards the exoplasmic head groups, the free
energy profile suggested a stable completely α-helical conformation. The MSD pep-
tide tilts to facilitate Arg694 snorkeling while preventing water molecules to interact
with the hydrophobic residues to maintain the α-helical conformation. A metastable
conformation kinked at Gly692 with an unfolded GXXXG motif was also observed
with RMSDα between 4 and 6 A˚. This is likely because an α-helical MSD with Arg
694
snorkeling towards the exoplasmic head groups resulted in water molecules in the
proximity of the glycines, which then can attack backbone hydrogen bonds involving
glycines. This model requires that the MSD subdomain between residues 694 through
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Figure 5.7: (Upper panels) Map of mean membrane thickness (measure as a distance between
centers of mass of lipid head groups in 10 A˚ square sections of each leaflet); color bar units in A˚.
Left, stable; right, metastable. (Lower panels) Side-view snapshots of stable (left) and metastable
(right) conformations.
707 anchor the “spike” to the viral membrane in the metastable state. However, re-
cent experimental results based on truncation mutants suggested that addition of just
three residues C-terminal to residue 694, up to Phe697, is enough to stably anchor
the Env glycoprotein in the membrane [49, 100]. Therefore, we believe that a MSD
model with Arg694 snorkeling towards the exoplasmic head groups is improbable in
the native spike, although it should not be discounted that these conformations could
still play a role in disruption of the viral membrane.
The free energy profile for the model with Arg694 snorkeling towards the endo-
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plasmic head groups also suggested that the completely α-helical conformation is
the most stable conformation. The possibility of the α-helix to tilt and Lys681 and
Arg694 to snorkel towards either leaflet’s head groups along with the observed shield-
ing of the backbone hydrogen bonds likely resulted in this stable conformation. A
similar phenomenon of shielding of backbone hydrogen bonds thereby stabilizing the
α-helical structure by the arginine side chain was previously observed in alanine rich
peptides [107]. This conformation is consistent with results from truncation studies
that show that addition of residues C-terminal to Arg694 increase surface expression by
better anchoring of the peptide with increasing number of residues in the α-helix [49].
Although this conformation explains the importance of the length of the subdomain
between 694 and 707 for the incorporation of the spike and the role of Arg705 in
destabilization of viral membrane and therefore fusion, it was also important that
this simulation predicted as metastable the experimentally hypothesized snorkeling
model of the MSD [49]. We also observed that the MSD peptide from Lys681 to Phe697
is enough to span the lipid bilayer and anchor the MSD.
The stable and metastable conformation observed in the Leu mutant model are
similar to the endoplasmic snorkeling model. This suggests that the MSD peptide
has a natural tendency to kink at Phe697 and the presence of a polar side chain in the
hydrophobic core and snorkeling towards the endoplasmic head groups facilitates the
kink. It should be noted that penetration of water molecules to the extent observed
in the endoplasmic snorkeling model was not observed in the Leu mutant model.
Both the Arg694 snorkeling models showed a consistent thinning of the lipid mem-
brane due to water penetration and lipid head groups interacting with Arg694. Cryo-
electron tomographic images of HIV-1 Env spike show an obvious decrease in mem-
brane thickness in the lower leaflet of the bilayer [108] leading us to speculate that
Arg694 snorkels towards the endoplasmic head groups in the native spike. Conversely,
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the Leu mutant model showed minimal membrane thinning in both the stable and
metastable state. The presence of water molecules in the hydrophobic core and mem-
brane thinning due to the presence of the polar sidechain of Arg694 likely have a role
in membrane destabilization during membrane fusion. These observations may there-
fore explain the loss of infectivity observed from experimental results when Arg694
was mutated into a Leu [100].
Based on these observations we hypothesize that the MSD exists in the metastable
kinked snorkeling model in the native spike. Conformational changes in the gp41
ectodomain during the formation of the pre-fusion intermediate perhaps result in
the MSD assuming a tilted, completely α-helical conformation. A tilted α-helix,
continuous from Lys681 to Arg707, further assists the penetration of water into the
membrane core to interact with Arg694. The GXXXG motif, although insignificant
for the incorporation of the native spike [50], is perhaps important to induce inter-
helical interactions and in maintaining gp41 MSD trimers during these conformational
changes [98, 99].
5.5 Conclusions
We sampled various conformations of the HIV-1 gp41 MSD in a cholesterol-rich
lipid bilayer based on two starting models, (i) with Arg694 snorkeling towards the ex-
oplasmic head groups and (ii) with Arg694 snorkeling towards the endoplasmic head
groups, using all-atom metadynamics calculations. We further prepare a third model
with Arg694 mutated into a Leucine. Based on our observations and previous ex-
perimental results, we hypothesize that the MSD assumes a conformation with the
mid-span Arg694 snorkeling towards the endoplasmic head groups in the native spike.
Furthermore, there are two conformations, a stable tilted α-helical conformation and
a metastable kinked snorkeling conformation, that the MSD likely can shuttle be-
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tween during conformational changes of the gp41 ectodomain. It was also observed
that the MSD residues from Lys681 to Phe697 are enough to span the bilayer and
effectively anchor gp41, consistent with experimental observations. MSD with Arg694
snorkeling towards endoplasmic head groups also resulted in significant thinning of
the membrane.
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Chapter 6: Model building HIV-1 gp41 ectodomain pre-fusion
intermediate
6.1 Introduction
The envelope (Env) glycoproteins of HIV-1 are comprised of non-covalently inter-
acting subunits of surface glycoprotein gp120 and transmembrane glycoprotein gp41
that are assembled in the form of trimeric spikes on the viral membrane. Gp120 is
responsible for viral tropism and binds to the cell surface receptor CD4 and core-
ceptor (CCR5/CXCR4). Gp120 binding results in the exposure of the hydrophobic
N-terminal fusion peptide of gp41 that is inserted into the target-cell membrane. Fol-
lowing FP insertion, the N- and C- heptad repeats (NHR and CHR respectively) of
gp41 form into an extended pre-fusion intermediate (PFI) conformation bridging the
viral and target-cell membranes. The NHR and CHR then fold into a thermally stable
six-helix bundle (6HB) bringing the viral and target-cell membranes into proximity
initiating fusion(Fig. 6.1). The structural information of HIV-1 gp41 in the 6HB form
has been solved using X-ray crystallography [109–111]. According to these structures,
the NHRs form into a parallel, trimeric coiled coil of α-helices. The three CHRs then
wrap antiparallel into the three interhelical grooves of the NHRs as α-helices. The
important features of 6HB involve a hydrophobic cavity in the interhelical groves of
the NHR core that includes residues Lys565, Leu566, Leu568, Thr569, Ile573, Leu576,
Val570, Trp571, Gly572, Lys574 and Gln577 from the NHR [109, 110, 112]. The hy-
drophobic residues in the CHR especially Trp628 and Trp631 are known to collapse
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into the hydrophobic cavity in the 6HB(Fig. 6.2). Further away from the flexible
linker hydrophobic interactions between residues Ile559 and Ile646 are thought to sta-
bilize the 6HB. However, the point mutation studies suggested that in general the
residues closer to the flexible linker on both the NHR and CHR are more important
for the formation and stability of the 6HB that those further away from it [113]. The
flexible linker is known to consist of three glycosylation sites at Asn611, Asn616 and
Asn624.
Several other enveloped viruses, including influenza, share a similar fusion mech-
anism. However, the native and final structures of these viral proteins are available
while that of HIV-1 gp41 is still elusive. With the gp41 ectodomain being the most
conserved region of the HIV-1 Env, research is now focused to understand the struc-
ture of the ectodomain in its native and pre-fusion intermediates. The purpose of this
chapter is to model build a complete 6HB and an extended state representing the PFI
of HIV-1 gp41 with NHR, the flexible linker connecting the two heptad repeats and
the CHR from existing structure (PDB access code: 1AIK) [109, 110]. The PFI was
then successfully folded into a stable 6HB using a combination of molecular dynamics
and targeted molecular dynamics (TMD). The interactions between the amino acids
in NHR and CHR and the final state were consistent with existing literature. The
mechanism of folding of PFI into 6HB is still speculative. However topological fea-
tures of the ectodomain, specifically the position of the CHRs in the extended state
and the flexible linker are at variance with current knowledge. It should be noted that
the goals of this exercise were to develop a basic knowledge of the HIV-1 ectodomain
and the specific interactions involved during the cascade of conformational changes
from PFI to 6HB, attempt at model building 6HB and PFI and test the ability of
molecular simulations to replicate the mechanism of folding.
67
6.2 Simulation methods and models
6.2.1 General methods
All simulations were performed using NAMD2.7b2 with the CHARMM force field
and explicit TIP3P water. The trajectories were visualized using VMD 1.8.7. Sec-
ondary structure restraints were applied on the α-helical subdomains of the ectodomain
during all vacuum simulations.
6.2.2 Model building gp41 ecotodomain six-helix bundle (6HB)
The initial structure of 6HB was obtained from the cystallographic date obtained
by Chan et. al (PDB access code: 1AIK) [109]. The structures consists of one NHR
and one CHR. The complete trimer to represent the known biologically significant
state can be obtained by using the coordinates provided in the structure informa-
tion for the other two NHR/CHR pairs. However, the flexible linker connecting
the C-terminus of the NHR to the N-terminus of the corresponding CHR is absent.
The complete sequence of the linker is given by 581 SGIVQQQNNLLRAIEAQQH-
LLQLTVWGIKQLQARIL 628 (HXB2R) [110]. The linker was applied as patch to
the C-terminus of the NHR in CHARMM. The disulfide link was applied between
Cys598 and Cys604(Fig. 6.1). The system with the NHR connected to the linker and
the CHR in vacuum were minimized for 1000 steps. The entire system was then
equilibrated using the NVT ensemble in vacuum for 100 ps at a temperature 310K.
The linker collapses at the disulfide link and forms a loop. The C-terminus of the
linker was then steered towards the N-terminus of the CHR using steered molecular
dynamics. cv-SMD was performed using a velocity of 0.1 A˚/ps in vacuum for 1 ns in
the NVT ensemble at a temperature of 310 K and the α-carbon of Tyr627 was used
as the SMD atom. The C-terminal of the linker was then applied as a patch to the
N-terminus of the CHR. The system containing one NHR and one CHR connected
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by the flexible linker was then used to generate a complete 6HB structure using the
coordinates provided in the structure. The system was then inspected for overlapping
atoms and minimized for 1000 steps. Equilibration of the system was performed in
the NVT ensemble at a temperature of 310 K for a total of 1 ns in vacuum.
The ectodomain system was then solvated with approximately 100,000 water
molecules, neutralized and brought to an ionic strength of 0.1 M by adding Na+
and Cl− ions. The solvated system was then volume equilibrated for 100 ps in the
NPT ensemble with a pressure of 1 bar before performing a 10 ns MD run in the
NVT ensemble.
6.2.3 Model building of gp41 ectodomain pre-fusion intermediate (PFI)
To model build the gp41 PFI, the monomeric NHR-linker-CHR complex described
in the previous section was used. SMD was used to steer the C-terminus of the CHR
along the axis of the 6HB in vacuum while the backbone α-carbons of NHR are
restrained. A steering velocity of 0.1 A˚/ps was used and the center-of-mass of Glu661
was used as the SMD atom. The simulations were performed at a temperature of 310
K in the NVT ensemble. Based on the estimate from influenza fusion proteins (HA),
gp41 was also assumed to span approximately 100 A˚ from the viral membrane to the
target-cell membrane in the extended state of the PFI. Since the 33 amino acid long
fusion peptide is absent in our structure, the distance between the N-terminus of the
NHR and the C-terminus of the CHR was targeted to be at least 80 A˚. The complete
trimer of extended ectodomains was prepared from the crystallographic coordinates
as explained in the previous section to obtain a model of the PFI in vacuum(Fig. 6.3).
The PFI system was then minimized for 1000 steps, equilibrated in the NVT ensemble
for 100 ps while the NHRs and the CHRs are restrained.
The PFI system was then solvated by adding water molecules and neutralized to
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0.1 M using Na+ and Cl− ions. Folding of PFI into 6HB was performed using MD
and TMD. TMD requires that the initial and final systems have the same number of
particles. Therefore, the final PFI system was ensured to have the similar number of
water molecules and ions as the 6HB system. The entire system was then subjected to
equilibration in the NPT ensemble for 100 ps at a pressure of 1 bar and temperature
of 310 K followed by equilibration the NVT ensemble at a temperature of 310 K for
a total of 10 ns.
6.2.4 Targeted molecular dynamics (TMD)
TMD was used to fold the PFI of the ectodomain into 6HB and was explained in
Section 2.5. The initial state was obtained after the 10 ns equilibration of PFI model.
The 6HB model equilibrated for 10 ns was used as the final state. All restraints were
released during TMD and the simulations were performed in the NVT ensemble.
The backbone α-carbons of the NHRs and CHRs were subjected to TMD forces. A
spring constant (k) of 200 kcal mol−1 A˚−2 was used and the TMD simulations were
performed for 10 ns.
6.3 Results
6.3.1 Molecular dynamics simulations of six-helix bundle and pre-fusion
intermediate
The RMSD profiles for the backbone C, Cα and N atoms of the 6HB, the linker and
the NHR/CHR subdomains during 10 ns of MD is provided in Fig. 6.4. As expected
the NHR/CHR subdomains are extremely stable in the 6HB. At approximately 7 ns
the C-terminus of one of the CHRs in the 6HB was observed to unfold from the stable
state that resulted in a peak in the RMSD profile. However, the interactions between
Ile599 and Ile646 stabilized the 6HB structure from further unfolding. Conversely, the
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linker is highly flexible and the the RMSD profile of the 6HB overall was influenced by
the fluctuations in the linker. The linker collapsed during the vacuum equilibration
that resulted in the glycosylation site being buried. In water, during the initial 10 ns
some of these glycosylation sites especially Asn611 and Asn616 were observed become
solvent accessible.
The PFI was extended using SMD and was distance between the N-terminal of
NHR and the C-terminal of the CHR was at least 80 A˚ in the extended conformation.
The NHR and CHR are approximately 50 A˚ each and there was minimal loss in
the interactions between residues of the CHR and NHR near the hydrophobic cavity.
Lys628 interactions with the residues in the hydrophobic cavity were still intact. Since,
secondary structure restraints were used the NHRs and the CHRs are intact α-helices.
The helical secondary structure was completely retained even after the 10 ns of MD
run.
During the 10 ns run the CHR α-helices were observed to “flip” and initiate
folding back into a stable six-helix bundle. The interactions between Trp628 and
Trp631 and the residues in the hydrophobic cavity were sufficient to initiate formation
of 6HB.However, classical molecular dynamics is likely insufficient to observe complete
folding of PFI into 6HB. Therefore, we used TMD to simulate complete folding of
PFI into 6HB.
6.3.2 Folding of pre-fusion intermediate into six-helix bundle using TMD
TMD run was started from the final configuration of the molecular dynamics
simulation of the PFI. Generally TMD drives the system from an initial conformation
to a target conformation linearly. The equilibrated six-helix bundle was provided as
the target conformation. Even during the TMD run the the CHRs were observed to
maintain intact α-helical conformation. The RMSD profile during the TMD run is
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provided in Fig. 6.5. The target RMSD varies evolves during the simulation while
the current RMSD is the instantaneous RMSD that follows target RMSD depending
upon the spring constant. Since, we used a “stiff” spring constant of 200 mol−1 A˚−2,
the current RMSD followed the target RMSD closely.
During the TMD run the secondary structure restraints and the spatial constraints
on the NHRs were removed. However, the trimeric NHR core was observed to be
intact through out the TMD simulation. In spite of the rigid spring constant used
in the TMD run the NHRs were observed to kink while residues Gln562 and Gln563
and the hydrogen bonding maintain the NHR core to facilitate interactions of Trp628,
Trp631 and Ile635 with the residues in the hydrophobic cavity and the subsequent
folding of CHRs into the hydrophobic grooves.
6.4 Discussion
The intent in this chapter is to model build a complete 6HB from the available
structural information, model build a pre-fusion intermediate from the 6HB using
SMD and existing knowledge of the PFI and to test the ability of molecular sim-
ulation techniques to fold PFI into 6HB. The available 6HB structure contains the
α-helical NHR and CHR subdomains. Therefore, we used the available sequence of
HIV-1 HXB2R to model build the flexible linker connecting the NHR and the CHR.
The 10 ns MD simulation of the 6HB structure was highly stable with the observed
fluctuations dominated by the flexible linker. In the modeled linker prior to the water-
solvated simulations the glycosylation sites at Asn611 were Asn616 buried in the bulky
linker. During the 10 ns run it was observed that the 4 of the 6 residues were solvent
accessible. Following the MD we used SMD to extend the ectodomain and model the
PFI.
The existing knowledge about influence (HA) transmembrane protein ectodomain
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structure in its low-pH conformation where the fusion peptide moves approximately
100 A˚ is used to model the PFI of HIV-1 gp41. The distance between the C-terminus
of the CHR and the N-terminus of the NHR without the 33 amino acide long fusion
peptide was 80 A˚. The obtained PFI structure retained the important interactions
between Trp628 and the residues in the hydrophobic cavity in the NHR core. These
interactions resulted in the PFI partially folding back towards a 6HB in a 10 ns MD
simulation. TO accelerate folding into 6HB we used TMD.
TMD successfully facilitated folding of PFI into 6HB by linearly driving the system
towards the target 6HB structure. Since, the restraints on the system were removed
the ability of the NHRs and CHRs to kink in order to fold into a stable 6HB was
observed. Also, the importance of the highly conserved glutamine residues Gln562 and
Gln563 to hold the NHR trimer was observed. Previous experimental point mutations
of these residues resulted in a complete loss of viral infectivity. The final conformation
restored the important structural features of 6HB, Trp628, Trp631 and Ile634 on the
CHRs collapsed into the hydrophobic pocket in the NHR trimer. The salt-bridge
between Lys574 and Asp632 was also restored. These interactions between residues
close to the flexible linker were also found to be important in the formation of 6HB
and viral infectivity. Further away from the linker hydrophobic interactions between
Ile559 in the NHR and Ile646 and Glu647 on the CHR that are important for the
stability of 6HB were also restored.
In spite of successfully modeling and folding PFI into a stable 6HB it should be
noted that the system is partially inconsistent with existing literature about native
spike and PFI. There are two competing hypotheses about the structure of gp41 in
the native spike based on spike structure obtained from cryo-electron tomography
images [108, 114–116]. Liu et. al suggested that the spike is connected to the viral
membrane in the form of a “stalk” that is approximately 35 A˚ wide [108]. In our PFI
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model the CHRs were at a distance between 38 to 41 A˚ from each other. Moreover,
the spike was observed to be in the form of a mushroom and the flexible linker was
thought to protrude to the side of the spike while the linker in our model would
essentially be hidden in the electron-tomography structure. Conversely, Zhu et. al
suggested that the base of the native spike is splayed apart in the form of a tripod
that compares well with our model of CHRs [115, 116]. A better model would likely
position the CHRs in the grooves between the flexible linkers.
Moreover, synthetic peptides prepared to replicate CHRs were observed to be
unstructured in isolation in water experimentally. Monoclonal antibodies could only
bind to CHRs following formation of 6HB suggesting conformational changes during
the formation of 6HB. Therefore, it was hypothesized that CHRs are unstructured
in water and require interactions with NHRs to obtain the α-helical conformation.
However, in our TMD simulation the CHR retained its α-helical conformation even
in the extended conformation and while folding into a 6HB. Apart from the relatively
short simulation time, the high spring constant used during TMD likely restricted the
simulation from sampling conformations farther away from the 6HB. Nevertheless,
these simulation proved that TMD can be successfully used to simulate folding of
PFI to 6HB and can be extended to study the the effect of the formation of 6HB on
viral and target-cell membranes.
6.5 Conclusions
In this chapter, we successfully model built a complete six-helix bundle and pre-
fusion intermediates of the HIV-1 gp41 transmembrane proteins. The models were
then used to study the interactions and mechanism of the conformational changes
from 6HB to PFI using TMD. Although some topological features of the models are
at a variance with existing literature, the specific interactions between the residues
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important for the formation and stability of 6HB were consistent with present knowl-
edge. Furthermore, TMD was successfully used to simulate the conformational change
from PFI to 6HB and the pros and cons of the simulation were discussed.
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Figure 6.1: A schematic cross-section of the model build six-helix bundle. The NHR(blue) and
CHR(red) structure were obtained from available crystallographic structural information (PDB).
The sequence of the linker(grey) was used to model build the complete structure
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Figure 6.2: A schematic cross-sections of the 6HB representing the hydrophobic groove (white) and
the deep hydrophobic cavity in the NHR trimeric core.Trp628 can be seen to interact with residues
in the hydrophobic cavity.
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Figure 6.3: A schematic cross-section of the model build pre-fusion intermediate. The PFI is
model built using the 6HB structure.
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Figure 6.4: The RMSD of the 6HB (blue), RMSD of the NHR/CHR domains (green) and the
RMSD of the linker (red) during 10 ns of MD run. The NHR/CHR domains can be observed to be
extremely stable.
Figure 6.5: Target RMSD (red) and instantaneous RMSD (green) of the TMD atoms during the
course of 10 ns TMD simulations. The stiff spring constant of 200 kcal mol−1A˚−2 resulted in the
instantaneous RMSD closely following the target RMSD.
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Chapter 7: Findings and Future Directions
7.1 Findings
Surface envelope glycoproteins of viruses have always been a major source of
vaccines and targets for drug molecules. With research now being focused to develop
cheap and potent vaccines and drug molecules to help prevent and cure the global
epidemic of AIDS, there is a renewed drive to understand the structure and function
of the HIV-1 surface envelope glycoproteins, gp120 and gp41. Although molecular
simulations are an excellent tool to study, visualize and analyze protein structure,
dynamics and function, the absence of complete crystallographic or NMR structural
information of gp41 resulted in inadequate simulation studies of the protein. In this
work, we studied the HIV-1 transmembrane protein (gp41), specifically two highly
conserved regions of gp41 (ectodomain and membrane-spanning domain), and we
also tried to understand its natural preference for cholesterol-rich domains in the cell
membranes to enter as well as derive its own envelope. The main goals of this work are
therefore, (i) to study the forces and free-energies of rupture of cholesterol-containing
bilayers, (ii) to explore the structure-function relationship of the membrane-spanning
domain of HIV-1 gp41 destabilization of lipid membranes and (iii) to simulate the
folding of a pre-fusion intermediate of gp41 into a stable six-helix bundle. In order
to circumvent the absence of structural information of these systems we model built
(i) the membrane-spanning domain using the available sequence and the α-helical
structure of the viral protein Vpu, (ii) the complete 6HB with the flexible linker from
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the available linker sequence and the ectodomain structure (PDB access code: 1AIK)
and (iii) the PFI from the 6HB.
In Chapter 3, we computed the structural and dynamical effects of cholesterol on
lipid membrane properties and validated our results with existing knowledge. We
further calculated the forces and free-energies of rupture of pure POPC and POPC/-
cholesterol membranes but simulating mechanical insertion of a pristine carbon nan-
otube into a lipid bilayer. We found that while the force of insertion is similar for both
pure POPC and POPC/cholesterol bilayers the free-energy of insertion is significantly
higher for cholesterol-containing bilayers. Since, cholesterol is known to increase the
rigidity of the bilayers by straightening the lipid tails the increased free-energy is
likely the results of increased interactions between the lipid tails and the nanotube.
Considering these observations, it can be hypothesized that cholesterol-containing
lipid bilayers increase the membrane anchoring of non-polar structures. The higher
free-energy required for destabilization also likely explains the formation of oligomers
of fusion protein in viruses. Moreover, it was also found that higher-cholesterol con-
tent in membranes resulted in higher mechanical destabilization and likely a larger
fusion pore.
In Chapters 4 and 5, we explored the structure of the MSD in water and cholesterol-
containing lipid membranes. We found that, in water the MSD exits in the form of a
stable kinked helix with the kink at the GXXXG motif. However, it can shuttle be-
tween the stable kinked structure and a metastable loop structure with a second kink
at Phe697 across a low energy barrier and that it is highly metastable as a complete
α-helix. In a lipid membranes, we used two models based on the snorkeling direction
(Exoplasmic or Endoplasmic) of the mid-span Arg694 side-chain and a third model
with Arg694→Leu point mutation to replace Arg694 which abrogates infectivity. In
all the models, we found that the MSD assumes a stable completely α-helical con-
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formations and a metastable kinked conformations. In the endoplasmic snorkeling
model, which is likely the naturally occurring direction of the Arg694 sidechain, the
metastable state observed in our simulations compared well with existing hypothesis
based on experimental observations. Moreover, we also found that in the presence
of mid-span Arg694 the MSD significantly decreases membrane thickness in the prox-
imity of the peptide in both the stable and metastable conformations. Mutation of
Arg694 into a relatively hydrophobic Leu resulted in minimal effect of the MSD on
the lipid bilayer thickness. These observations likely explain the presence of a polar
residue in the hydrophobic environments of the viral membrane core and the loss of
viral infectivity upon mutation.
In Chapter 6, we model built a complete 6HB and PFI and studied the folding
of PFI into 6HB. These simulations suggested the importance of the presence of
highly conserved residues in the gp41 ectodomain. Although, the models provided
insights into the structure and folding of 6HB, it was concluded that the models can
be improved to better represent current knowledge of gp41 in the native spike and
the pre-fusion intermediate.
At a fundamental level, membrane fusion requires two steps, (i) opposing mem-
branes are brought into close proximity and (ii) membranes are destabilized to facil-
itate lipid mixing. We used model built structures to study the structure-function
relationship of HIV-1 gp41 during membrane fusion using all-atom simulations. HIV-
1 consists of a viral envelope rich in cholesterol. The presence of cholesterol increases
the rigidity of lipid membranes that is likely required to maintain the high internal
pressure of a mature virion. In this work we showed that the presence of a mid-span
Arg694 results in significant thinning of the lipid membrane and penetration of water
molecules into the membrane core thereby weakening the membrane and priming it
for fusion.
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7.2 Future directions
We propose the following suggestions to motivate further research in protein-
membrane interactions and HIV-1 gp41 structure and function in membrane fusion:
(i) Biological membranes are complex macromolecular structures with a variety
of lipid molecules that influence membrane and protein structure and function. With
force field parameters available for a variety of lipids and becoming increasing accurate
complex bilayers can be used to study both the structure of proteins in a relatively
realistic membranes and also the role each of these lipids play in the membrane and
protein function.
(ii) The MSD is a highly conserved peptide of HIV-1 gp41 and contains a GXXXG
motif and charged residues at Lys681, Arg705 and Arg707. Each of these residues
were found to be important for viral infectivity from recovery-of-function and point
mutations. Studying the role of these residues in MSD and membrane structure by
simulating point mutations can offer excellent insight into their role in infectivity.
(iii) Understanding the mechanism by which various other fusion proteins facilitate
membrane fusion is also important. For example, SNARE proteins also consist of a
transmembrane domain that anchors the protein to both the vesicle and the target
membranes. However, a midspan charged residue that weakens the membranes is
absent. Therefore, understanding the mechanism by which various fusion proteins
destabilize lipid membranes using both experimental and computational methods is
important.
(iv) The CHRs were observed to be α-helical in our simulations in both the 6HB
and PFI. However, previous experimental results suggested that the CHRs are un-
structured when isolated form the NHR trimer. The structure of CHR can therefore
be studied and the knowledge can be used to understand the structure of the viral
spike, the mechanism of formation of 6HB and to build better models of PFI.
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(v) Model built structures of 6HB and PFI can be fit to cryo-electron tomography
images and improved by comparing them with the unknown densities.
(vi) The role of the linker in membrane fusion is still not completely studied.
It was observed from previous experimental studies that the entire flexible linker
is not essential for the formation of a stable 6HB. However, the role of the linker
in membrane destabilization and fusion is still not completely understood. Further
studies, both experimental and computational, are likely required to study the role
of the flexible linker and its sequence in membrane fusion.
(vii) Finally, the model build structures of 6HB and PFI although not completely
accurate can be used to understand their role in membrane destabilization. Ideally,
a complete viral membrane to target-cell membrane system with gp41 bridging the
two membranes in the PFI state can be used as a starting state and the effects of
formation of 6HB on the MSD, fusion peptide, the viral and target-cell membrane
could be studied. However, the system will be extremely large and computationally
expensive and hard to simulate.
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